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ABSTRACT OF DISSERTATION

MOLECULAR MECHANISM OF HUMAN MISMATCH REPAIR INITIATION

DNA mismatch repair (MMR) is a highly conserved pathway that maintains genomic
stability primarily by correcting mismatches generated during DNA replication. MMR
deficiency leads to microsatellite instability (MSI), which is a hallmark of HNPCC
(Hereditary Nonpolyposis Colorectal Cancer). Human mismatch repair is initiated by
MutSα, a heterodimer of MSH2 and MSH6 subunits. Mismatch binding by MutSα triggers
a series of downstream MMR events including interacting and communicating with other
MMR proteins. The ATPase domain of MutSα is situated in the C-termini of its both
subunits, and ATP binding is required for dissociation of MutSα from a mismatch. In
eukaryotic cells, a strand break, which resides either 3’ or 5’ to the mismatch up to several
hundred base pair away, determines the strand specificity of MMR. However, in spite of
extensive studies, the mechanism by which MutSα locates and senses a nick from the
mismatch, and coordinates the subsequent steps of MMR remains poorly understood. Two
controversial models have been proposed to explain how the mismatch and the strand
break communicate each other. Sliding model proposes that MutSα slides along the DNA
helix from the mismatch to the strand break in an ATP binding-dependent but not ATP
hydrolysis-dependent manner. Stationary model postulates that MutSα remains bound at
the mismatch, and a protein-mediated DNA loop forms, physically bringing the mismatch
and the nick in contact. Here, we tested these models in vitro, using a circular plasmid
DNA substrate with a single GT mismatch and two Lac repressor (Lac I) binding sites as
conditional physical 'roadblocks', one on either side of the mismatch, which when present,
prevent MutSα from sliding bi-directionally along the DNA. The results showed that DNA
excision initiates under conditions that block MutSα sliding, suggesting that initiation of
excision is independent of whether MutSα slides from the mismatch to the nick. This result
implies that the communication between the mismatch and the nick is likely through
interactions between the mismatch-bound MutSα and other MMR components at the
strand break, supporting the stationary model. Therefore, these studies provide significant
insight into the mechanisms of mismatch correction in human cells.
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CHAPTER ONE
INTRODUCTION

1-1. Genomic Instability and Carcinogenesis
Genomic instability which refers to a high frequency of mutations within the genome
during the life cycle of cells is the hallmark of cancers. It is a major driving force in
carcinogenesis and can be caused by genetic or epigenetic mechanisms (Waddington 1940,
Holliday and Pugh 1975, Issa 2000, Nguyen and Massague 2007). In general, genomic
instability occurs as a result of exposure to high levels of DNA damaging agents, or because
of defective DNA repair pathways. Exogenous agents that damage DNA or DNA precursors
include physical or chemical damage such as ultraviolet light (UV), ionizing radiation, or
reactive chemicals. Defective DNA replication can also lead to high levels of
misincorporated nucleotides, strand slippage-induced small deletions or insertions
(Modrich 1989, Modrich 1997) while aberrant homologous recombination events also
contribute to genome instability (Holliday 2007). Although mutations in DNA repair genes
are infrequent specifically in sporadic (non-hereditary) cancers (Drake 1991, Drake 1999),
they are common in hereditary cancers. However, genomic instability is reduced by
effective, error-free and somewhat redundant high capacity DNA repair pathways,
high-fidelity DNA replication in S-phase, precise chromosome segregation during mitosis,
coordinated cell cycle progression, and cell death pathways that eliminate severely
damaged cells and/or lower the rate at which mutant cells proliferate.

1-2. DNA Mismatch Repair and Cancer
DNA repair systems provide a crucial defense mechanism against DNA damage caused
by exogenous or endogenous agents. MMR is a highly conserved DNA repair pathway that
maintains genomic stability primarily by correcting base-base or small insertion/deletion
mismatches. MMR enhances the fidelity of DNA replication 100–1000 fold (Kolodner
1996, Schofield and Hsieh 2003, Iyer, Pluciennik et al. 2006). Defects in MMR increase the
spontaneous mutation rate in human cells (Eshleman and Markowitz 1995) and are tightly
linked to hereditary non-polyposis colon cancer (HNPCC) and microsatellite instability
(MSI). Majority of HNPCC patients exhibits MSI, which is a hallmark of HNPCC
(Loukola, Eklin et al. 2001). Microsatellites are simple 1-6 bp tandem DNA sequence
repeats typically present in 100s of copies distributed in coding and non-coding regions of
the genome (Chen, Chen et al. 1997). Instability in microsatellite repeats is caused by the
1

failure to repair small slip-mispairing loops that form during meiotic DNA replication
(Tautz and Schlotterer 1994), which is inheritently hypermutable. Instability in
microsatellite repeats gives rise to generation of small insertion-deletion (ID) mispairs (or
loops), which are typically repaired by MMR. Therefore, MSI is diagnostic for MMR
dysfunction and for hereditary nonpolyposis colon cancer (HNPCC) and acute myeloid
leukemia (AML) (Lynch and de la Chapelle 1999, Umar and Srivastava 2004).

1-2-a. Colorectal Cancer (HNPCC and sporadic MSI-CRC)
Approximately 10% of all colorectal cancer patients carry inherited mutations in MMR
genes and are diagnosed with the autosomal dominant disorder HNPCC (also called Lynch
syndrome). HNPCC is characterized by early onset adenomatous colorectal polyps (~44
years old) and increased risk of developing colorectal, endometrial, stomach, small intestine
and ovarian cancers as well as leukemia (Kohlmann and Gruber 1993). HNPCC-linked
germline mutations are primarily observed in MSH2 and MLH1, but are also occasionally
found in MSH6, MSH3 and PMS2 (Peltomaki and Vasen 1997, Lynch and de la Chapelle
1999). This thus strongly supports the association of MMR deficiency with HNPCC
syndrome. Discovery of the strong link between MMR dysfunction and HNPCC stimulated
investigation into mechanisms of MMR in human cells, which provides significant insights
into finding treatment of HNPCC. Interestingly, approximately 15% of sporadic human
colorectal cancers lack detectable mutations in known human MMR genes, suggesting
either that mutations in other (not yet identified) MMR genes or mutations in non-MMR
genes contribute to development of colorectal cancer, or that epigenetic changes in MMR
gene expression play a role (Bellizzi and Frankel 2009). In fact, hypermethylation in the
promoter region of MLH1 has been observed in MSI- positive colorectal cancer cells, which
leads to silencing of MLH1 gene expression (Kane, Loda et al. 1997, Herman, Umar et al.
1998). This modification reduces and/or blocks expression of MLH1, causing a mutator
phenotype, which indicates that epigenetic modifications can also be responsible for a
mutator phenotype.

1-2-b. Acute Myeloid Leukemia (AML)
In addition to HNPCC, MMR defects increase the incidence of acute myeloid leukemia
(AML), which is one of the most common adult onset acute leukemia (Mao, Pan et al. 2008,
Mao, Yuan et al. 2008). The incidence of AML is higher in men than in women and
increases with age, but is rare in individuals younger than 40 years old. It is characterized by
rapid proliferation of abnormal white blood cells in the bone marrow, frequent infections
2

and increased risk of bleeding. Non-genetic risk factors for AML include exposure to
cigarette smoke, radiation, chemotherapy, and other genetic disorders including Down
syndrome (trisomy 21). Basically, somatic mutation is not the only mechanism in which
cancers arise, but the accumulation of somatic mutation is the only process that can account
for cancer progression in different ages (Frank and Nowak 2004). In addition, somatic
mutations in some of the genes involved in MMR pathway have been identified in AML
patients while either being at the time of diagnosis or after leukemia relapse, suggesting that
MMR defects are involved in the formation and progression of AML (Mao, Pan et al. 2008,
Mao, Yuan et al. 2008). Interestingly, leukemic cells from AML patients can display higher
mutation rate and a more aggressive phenotype during relapse than at time of diagnosis, and
mutations in MMR genes are found more frequently in leukemic cells from AML patients
during relapse (Mao, Yuan et al. 2008). Therefore, the appropriate expression of MMR
genes would modulate over the process of AML cancer progression, decreasing the
mutation rate and eventually enhancing genomic stability.

1-3. DNA Mismatch Repair
The MMR deficiency contributes to exhibition of mutator phenotype, and mutation
rates in tumor cells caused by MMR deficiency are up to 1000 fold higher than normal cells.
The MMR plays an essential role in cancer avoidance, because it increases genomic
stability, restoring DNA homeostasis in cells (Li 2008). MMR proteins (Table 1.1) and
mechanisms are highly conserved in prokaryotes and eukaryotes. Mismatch repair generally
involves three steps: 1) mismatch recognition, 2) excision (removal of a mismatch), and 3)
DNA resynthesis. The MMR mechanism in prokaryotes and eukaryotes differs during
initiation, and the strand discrimination signal, which differentiates the newly synthesized
strand from the template strand, is also thought to differ (see below for further discussion)
(Lahue, Au et al. 1989, Constantin, Dzantiev et al. 2005, Zhang, Yuan et al. 2005).

3

Table 1.1 MMR components and functions
E.coli

Human

(MutS)2

hMutSα
(MSH2-MSH6)

Function
Recognition of DNA
mismatch or damage

hMutSβ
(MSH2-MSH3)
(MutL)2

Nucleotide Mispair
or 1-2 IDs
2-16 ID Loops

hMutLα
(MLH1-PMS2)

Molecular matchmaker, Endonuclease activity,
and Termination of mismatch-provoked excision

hMutLβ
(MLH1-PMS1)

Unknown

hMutLγ
(MLH1-MLH3)

Unknown

MutH

Unknown

Strand discrimination

UvrD

Unknown

DNA helicase

Exo I, Exo VII,
Exo X, Rec J

Exo I

DNA mismatch-provoked excision

Pol III
holoenzyme

Pol δ

DNA
Resynthesis

SSB

RPA, HMGB1

ssDNA binding/protection, enhancement of MMR

RFC

ssDNA binding and PCNA loading for 3’
nick-directed MMR

DNA ligase I

Ligation of a nick

DNA Ligase

PCNA

3’ nick-directed MMR

*Modified from Li G.M.; Mechanism and functions of DNA mismatch repair, Cell
Research, 18, 85-98, (2008) (Li 2008)
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Given the major function of MMR in correcting biosynthetic errors, MMR also plays a
crucial role in DNA damage-induced cell cycle arrest and apoptosis (programmed cell
death) (Stojic, Brun et al. 2004, Li 2008). Thus, defects in MMR not only lead to
carcinogenesis, but also render cancer cells highly resistant to cytotoxic agents. Treatment
of cells with DNA damaging agents such as an alkylating agent,
N-methyl-N′-nitro-Nnitrosoguanidine MMR (MNNG), generally stimulates cell death.
However, MMR defective cells cannot trigger apoptosis because MMR proteins are
involved in apoptosis pathway, resulting in drug resistance. Since most cytotoxic agents are
used in chemotherapy, the cancer patients with defects in MMR proteins are hard to be
treated by chemotherapeutic drugs. Therefore, understanding MMR mechanism is
necessary for developing chemotherapeutic drugs to treat MMR deficiency-induced
cancers.

1-3-a. Mismatch Repair in Escherichia coli
The MMR pathway in E.coli was elucidated in great molecular detail by Paul Modrich’s
laboratory in the late 1980’s. Recombinant DNA technology was used to clone E. coli
MMR genes and an in vitro assay was used to purify MutS, MutL and MutH. Then, MMR
was reconstituted in vitro using purified proteins, and the components of the MMR pathway
were found to include four exonucleases (ExoI, ExoVII, ExoX, and RecJ), DNA helicase II
(MutU/UvrD), single-stranded DNA binding protein (SSB), DNA polymerase III
holoenzyme, and DNA ligase, as well as MutS, MutL and MutH (Table 1.1). In E.coli (Su
and Modrich 1986, Grilley, Welsh et al. 1989, Kunkel and Erie 2005), MMR is initiated by
MutS, an enzyme that recognizes all base-base mismatches except C:C. In order of relative
affinity, MutS binds G:T, A:C, G:A, T:C, A:A, G:G, T:T, G:A, C:T mispairs (Kramer,
Kramer et al. 1984, Dohet, Wagner et al. 1985, Su, Lahue et al. 1988). MutS also binds
insertion-deletion (ID) mispairs up to four bases in length (Dohet, Wagner et al. 1985,
Parker and Marinus 1992). MutS forms a homodimer and possesses intrinsic ATPase,
which is essential for its function in MMR. MutS is recruited to mismatches by β-clamp, a
critical component of DNA polymerase III holoenzyme and a processivity factor in DNA
replication and repair (Lopez de Saro and O'Donnell 2001). After mismatch recognition by
MutS, MutS recruits MutL to the DNA (Grilley, Welsh et al. 1989), stimulating
ATP-dependent translocation of the MutS–MutL complex (Allen, Makhov et al. 1997). The
physical interaction of MutS with MutL enhances mismatch recognition, and the MutS /
MutL complex recruits MutH and UvrD (DNA helicase II). Like MutS, MutL possesses an
ATPase activity. As mentioned above, the major distinction of E.coli MMR from human
MMR is how to discriminate between newly synthesized strand and template strand. In
5

E.coli, the strand specificity of MMR is determined by the asymmetry of hemimethyled
dGATC sites (Schofield and Hsieh 2003, Kunkel and Erie 2005), which appears transiently
during DNA replication. After DNA replication, the hemi-methylated dGATC sites are
rapidly converted to their fully methylated form by DNA adenine methylase (Dam
methylase) by addition of a methyl group to the N6 position of the adenine in nascent DNA
(Junop, Obmolova et al. 2001). However, the newly synthesized strand remains transiently
unmethylated during DNA replication, which is called hemimethylated DNA. MutH, whose
endonuclease activity is stimulated by MutS / MutL complex, recognizes the asymmetry of
hemimethylated DNA (Ban and Yang 1998) and makes a strand specific nick on the
daughter (unmethylated) DNA strand (Au, Welsh et al. 1992, Modrich and Lahue 1996).
This mechanism is capable of recognizing a hemimethylated dGATC site as a strand
specificity signal up to 1 kb 3’ or 5’ away from the mismatch. The nick becomes the entry
point for DNA excision, which is catalyzed by one of four exonucleases (Rec J, Exo I, Exo
VII or ExoX) and UvrD helicase, which unwinds dsDNA. Single-strand binding protein
(SSB) binds to and protects the template DNA strand from nuclease attack, while the
nick-containing strand is degraded by the exonuclease. The DNA excision proceeds
bidirectionally in E.coli, either 5’→3’ or 3’→5’. After removal of up to or beyond the DNA
mismatch, the single-stranded DNA gap is filled in by DNA polymerase holoenzyme III,
and the nick is ligated by DNA ligase. (Figure 1.1)

6

Figure 1.1 Schematic representation of the E. coli MMR.
E.coli mismatch repair is initiated by MutS, which recognizes the mismatch and recruits
MutL to form the MutS-MutL complex. MutH, which has endonuclease activity, binds and
then creates a strand break at the newly synthesized strand of hemimethylated dGATC sites.
Excision is initiated at the nick by UvrD and 5'-3' or 3'-5' exonuclease, depending on the
location of the nick relative to the mismatch. SSB binds the parental strand and prevents its
degradation by nucleases. The single-stranded gap is filled in by DNA polymerase
holoenzyme III, and the nick is sealed by DNA ligase.

7

1-3-b. Mismatch Repair in Human Cells
Human MMR share many features including nick-dependent specificity and
bi-directionality with E.coli MMR, indicating that MMR is a highly conserved pathway.
However, eukaryotic MMR is more complex and does not involve hemimethylated DNA as
a strand specificity signal. The number of components is increased in human MMR (Table
1.1). Although a human homolog of MutH has not been identified (Kunkel and Erie 2005),
the process still involves a strand specific nick as a strand discrimination signal. However,
discontinuities between Okazaki fragments on the lagging strand or the 3’ terminus on the
leading strand might also play a role in strand discrimination in human MMR, in which
hemimethylated dGATC site does not reside (Lopez de Saro and O'Donnell 2001). In
human cells, 5 genes encode distinct MutS homologs (MSH2, MSH3, MSH6, MSH4,
MSH5), and although bacterial MutS is active as homodimer, human MutS is active as a
heterodimer. The most abundant MutS heterodimers are MutSα (MSH2-MSH6) and MutSβ
(MSH2-MSH3) (Drummond, Li et al. 1995, Genschel, Littman et al. 1998, Bocker,
Barusevicius et al. 1999, Kneitz, Cohen et al. 2000). MutSα recognizes base-base
mismatches and small insertion/deletions (IDs) (1 or 2 bases) whereas MutSβ recognizes
longer IDs than 2 bases (Kunkel and Erie 2005). Both MutSα and MutSβ possess intrinsic
ATPase activity and initiate MMR by recognizing and binding the mismatch. Human MutL
homologs also form heterodimers including MutLα (MLH1-PMS2), MutLβ
(MLH1-PMS1) and MutLγ (MLH1-MLH3) (Li and Modrich 1995, Porter, Westmoreland
et al. 1996, Wang and Kung 2002), but only MutLα is thought to be involved in MMR. The
biological role of MutLβ is not identified, while MutLγ is known to play a role in meiosis.
MutL has weak ATPase acivity and binds nonspecifically to DNA, and is recruited by
MutS binding to the mismatch (Kunkel and Erie 2005). MutL is required for termination
of mismatch-provoked excision (Zhang, Yuan et al. 2005) and for initiation of 3’
nick-directed MMR serving as an endonuclease (Kunkel and Erie 2005, Kadyrov, Dzantiev
et al. 2006, Li 2008). Since human EXO1 exhibits only 5’ to 3’ exonuclease, MutLα is
required for 3’ nick-directed MMR to create a nick at 5’ side of the mismatch where EXO1
is loaded onto (Kadyrov, Dzantiev et al. 2006). However, knockdown of EXO1 does not
cause a mutator phenotype as strong as knockdown of MutSα or MutLα, suggesting that
other nucleases may also be involved in MMR (Genschel and Modrich 2003, Wei, Clark et
al. 2003). Other MMR components such as RFC (Replication Factor C) and PCNA
(Proliferating Cell Nuclear Antigen) are required to activate MutLα endonuclease
(Kadyrov, Holmes et al. 2007, Pluciennik, Dzantiev et al. 2010). RFC binds and then loads
PCNA onto DNA, and PCNA, which is a processivity factor for DNA polymerase, interacts
with several proteins through PIP (PCNA Interaction Proteins) boxes. The PIP box is an 8
amino acids motif: QXXhXXaa (Warbrick 1998, Xu, Zhang et al. 2001). It has been
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reported that PCNA enhances the binding ability of MutSα to mismatches, which is induced
by PIP-mediated protein-protein interactions (Flores-Rozas, Clark et al. 2000, Shell,
Putnam et al. 2007). HMGB1 is a non-histone chromatin protein that facilitates
protein-protein interactions and bends DNA molecules (Bustin 1999). It is also involved in
mismatch recognition: it interacts physically with MSH2 and MLH1 and enhances
mismatch-provoked excision (Yuan, Gu et al. 2004, Zhang, Yuan et al. 2005). Following
removal of the mismatch, the gap generated by excision is filled in by DNA polymerase δ
with the help of PCNA and RFC, and the nick is ligated by a DNA ligase (Modrich 1991,
Hsieh 2001, Kunkel and Erie 2005).
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Figure 1.2 Schematic representation of the human MMR.
The mechanism of human MMR is similar to that of E.coli MMR, being strand specific,
bi-directional and nick-directed. The human MMR is initiated by mismatch recognition of
MutS. Mismatch binding of MutS triggers downstream signal of MMR including
recuitments of MutL to the DNA and EXO1 to the strand break. Following the removal of
the mismatch by excision, the gap on the newly synthesized strand is filled-in by DNA
polymerases, and the nick is sealed by a DNA ligase. (Figure adapted from Janice Ortega's
dissertation, under preparation)
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1-4. Characteristics of MutSα protein
MutSα exists as a heterodimer that consists of two subunits, MSH2 and MSH6, each of
which has five functional domains (Figure 1.3): 1) Mismatch binding (1-124 in MSH2/
362-518 in MSH6), 2) Connector (125-297 in MSH2/ 519-717 in MSH6), 3) Levers
(300-456 and 554-619 in MSH2/ 718-934 and 1009-1075 in MSH6), 4) Clamp (457-553 in
MSH2/ 935-1008 in MSH6), and 5) ATPase (620-885 in MSH2/ 1076-1355 in MSH6)
(Warren, Pohlhaus et al. 2007).

Figure 1.3 Structure of MutSα. (adapted from (Warren, Pohlhaus et al. 2007))
Each subunit of MutSα has 5 functional domains, color-coded as follows: blue, mismatch
binding; green, connector; yellow, levers; orange, clamp; red, ATPase. A) Schematic
showing color-coded domain structure for E. coli MutS, hMSH2 and hMSH6. B) Ribbon
diagram representing X-ray structure of MutSa.
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MMR is initiated by MutSα (MSH2/MSH6). Previous studies have shown that MSH6
is unstable in the absence of its heterodimer partner, MSH2. Interestingly, only MSH6, but
not MSH2, has a conserved Phe-X-Glu motif that recognizes and directly binds to a
mismatch (Lamers, Perrakis et al. 2000, Obmolova, Ban et al. 2000, Warren, Pohlhaus et al.
2007, Edelbrock, Kaliyaperumal et al. 2013). The phenylalanine (Phe) residue in
Phe-X-Glu motif stacks with a mismatched base and the glutamate (Glu) residue forms a
hydrogen bond with the N-3 of a mismatched thymine or the N-7 of mismatched purine
(Lamers, Perrakis et al. 2000, Obmolova, Ban et al. 2000, Warren, Pohlhaus et al. 2007,
Edelbrock, Kaliyaperumal et al. 2013) (Figure 1.4).
A.
B.

Figure 1.4 Mismatch Binding Mode of MutSα. (adapted from (Warren, Pohlhaus et al.
2007))
(A) Ribbon diagram structure of mismatch-bound MutS complexed with ADP. MSH6 is
shown in blue, MSH2 in red, mismatched DNA in green, ADP in yellow, and Mg2+ ions in
green spheres. (B) Interactions between MSH6 domain 1 with a G-T mispair and an
adjacent base pair. In upper diagram, base pairs are represented with stick diagrams, and
electrostatic surface potential is represented by shaded background (shown as sticks under a
semitransparent electrostatic surface).
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MutSα possess intrinsic ATPase activity, which belongs to the ATP binding cassette
(ABC) superfamily. Mutations in the ATPase domains of MSH2 and MSH6 impair MMR,
indicating that the ATPase of MutSα is essential during MMR (Iaccarino, Marra et al. 1998,
Dufner, Marra et al. 2000). Both MSH2 and MSH6 have ATPase domains that contain
highly conserved Walker A and Walker B motifs (Hopfner and Tainer 2003): The Walker A
motif- GXXXXGKS/T is the site for nucleotide binding, and the Walker B motif- DD/EXX
where aspartic acid is required for ATP hydrolysis (Ramakrishnan, Dani et al. 2002). MSH6
has higher affinity for ATP than MSH2, and stable binding of ATP to MSH6 decreases the
affinity of MSH2 for ADP, suggesting that MSH2 and MSH6 have different affinities for
the nucleotides (Antony and Hingorani 2003, Martik, Baitinger et al. 2004) . The ATPase
domain is the most highly conserved region of MSH2/6 (Warren, Pohlhaus et al. 2007) and
is involved in MutSα dimerization (Figure 1.4). The positive charge of the clamp region
interacts with the negative charge of the DNA backbone to induce a clamp-like binding
pocket in the presence of DNA, and MutSα simultaneously binds ATP and ADP
(Blackwell, Bjornson et al. 1998, Blackwell, Martik et al. 1998, Bjornson, Allen et al. 2000).
Consequently, ATP binding of MutSα induces its conformational change and then
modulates mismatch binding (Figure 1.5). Its ATP binding promotes tightening of the
clamp around DNA and initiates sliding along the DNA. However, ATP inhibits mismatch
binding by MutSα, subsequently being exchanged for ADP (Gradia, Acharya et al. 1997,
Gradia, Subramanian et al. 1999, Wilson, Guerrette et al. 1999, Acharya, Foster et al. 2003,
Mendillo, Mazur et al. 2005). Dissociation of MutSα from the mismatch is facilitated by its
ATP binding, which results in signaling a series of downstream MMR events (Drummond,
Li et al. 1995, Alani, Sokolsky et al. 1997, Gradia, Subramanian et al. 1999). In spite of the
extensive studies regarding biochemical functions of MutS, the role of MutSα ATPase,
and the requirement for ATP hydrolysis during MMR remains unclear. Although ATPase
activity of MutSα is obviously essential for its function in MMR, whether ATP hydrolysis is
required for the initiation of MMR is still under debate.
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Figure 1.5 Proposed conformational change of MutSα in the presence of nucleotide.
(adapted from (Lamers, Georgijevic et al. 2004))
(A and B) MutSα binds and hydrolyzes ATP in the absence of a mismatch, releasing
phosphate. (C and D) MutSα binds to a mismatch in the ADP bound state (short-lived form),
and ADP is rapidly replaced with ATP. ATP binding triggers conformational change,
resulting in a sliding (long-lived form). The MutSα sliding clamp complexed with ATP
facilitates itds dissociation from the mismatch and slides along the DNA.

1-5. Involvement of MutSα in Initiation of Mismatch Repair
A strand break is indispensable of discriminating the newly synthesized strand
comtaining a mismatch from the parental strand to initiate MMR in human. In spite of
improving effort and progress to identify MMR components over the years, how
mismatch-bound MutSα interacts with the strand break to initiate MMR remains a matter of
debate. Since the strand break is located several hundred base pairs away from the mismatch
in vivo, how two physically distant sites communicate each other has been concerned.
Several models to explain initiation of MMR in human cells have been developed.
These models are generally classified into “stationary (trans)” or “moving (cis)” models.
The “stationary” model (Figure 1.6 right) postulates that MutSα remains bound to the
mismatch, while interactions of MMR proteins are attributed to DNA bending or looping
that brings two physical distant sites in proximity (Junop, Obmolova et al. 2001, Guarne,
Ramon-Maiques et al. 2004). This model implies the ATPase activity of MutS is required
for mismatch reconition and MutS interactions with other MMR proteins are required to
trigger downstream MMR events.
On the other hand, another proposed model, which is called the “moving” or “cis”,
propose movement of MMR proteins along the DNA, and are based on the observation that
ATP binding induces a conformational change in MutS, ATP to ADP exchange, and
movement of MutS along the DNA. There are two ‘moving’ models: one postulates
translocation and the other postulates sliding. The translocation model (Figure 1.6 left)
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proposes that MutS binds to a mismatch in a nucleotide-free state. ATP binding of MutS
reduces its mismatch-binding affinity, and ATP hydrolysis drives unidirectional
translocation of MutS along the DNA away from the mismatch. This model is supported by
an electron microscopy study demonstrating that MutS mediates formation of DNA loops at
mismatches in an ATP hydrolysis-dependent manner (Allen, Makhov et al. 1997,
Blackwell, Bjornson et al. 1998, Blackwell, Martik et al. 1998). However, there is no
evidence showing that this model is is relevant to human MMR.
In the sliding model (Figure 1.6 middle), MutS searches for a mismatch in the
ADP-bound state, and mismatch binding induces conformational change, resulting in
exchange of ADP for ATP. This model invokes that MutS forms a “sliding clamp”, which
travels along the DNA until it encounters a strand discrimination signal (Gradia, Acharya et
al. 1997, Fishel 1998, Gradia, Subramanian et al. 1999, Jiang, Bai et al. 2005, Mendillo,
Mazur et al. 2005). This model posits that ATP binding, but not ATP hydrolysis, signals
downstream MMR events including recruitment of MutL to a ternery complex and
dissociation of MutS from the mismatch. SPR data has supported this model, showing that
MutS diffuses away from the mismatch faster in the presence of ATP than in the presence
of ADP or in the absence of nucleotide (Selmane, Schofield et al. 2003).
Because there is evidence for each model, none of them can be ruled out. Therefore, the
studies described in Chapters 3 and 4 of this dissertation were carried out to clarify the
molecular mechanism of MMR in human cells.
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Figure 1.6 Schematic diagrams of strand discrimination during MMR initiation in
human cells. (adapted from (Li 2008))
Human MMR targets the newly synthesized strand containing a strand break, because the
strand discrimination signal in human MMR is thought to involve a strand break several
hundred bp away from the mismatch. In the “stationary” or “trans” model (right),
ATP-bound MutS binds to the mismatch and remains bound at the mismatch, while the
DNA bends or forms a loop, allowing the mismatch and the nick in proximity; the DNA
looping process requires hydrolysis of ATP by MutS. There are two “moving-” or “cis-”
models for human MMR, the “molecular switch” or “sliding” model, and the
“translocation” model. The “translocation” model (Left panel) suggests that MutS binds to
a mismatch in the absence of nucleotide, ATP binding then releases MutS from the
mismatch, and ATP hydrolysis drives translocation of MutS away from the mismatch.
The sliding model proposes that ADP-bound MutS searches for a mismatch and mismatch
binding induces conformational change, resulting in exchange of ADP for ATP.
ATP-bound MutS then dissociates and moves away from the mismatch in an
ATP-hydrolysis independent manner.
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Research Objectives
Defects in human MMR genes, mainly MSH2 and MLH1, reduce replication fidelity in
human cells, increasing the spontaneous mutation rates and promoting carcinogenesis.
MMR deficiency is tightly linked to HNPCC and increases risk of endometrial, ovarian,
gastric, cervical, breast, skin, lung, prostate, and bladder cancer as well as glioma, leukemia,
and lymphoma. Since MMR is also involved in apoptosis pathway, MMR defects cause a
decrease in apoptosis and increased survival of cells with DNA damage. Therefore, tumors
that carry defects in MMR are resistant to chemotherapeutic drugs such as temozolomide,
procarbazine, or cisplatin, which induce apoptotic death in proliferating cells (Li 2008).
Human MMR is initiated by MutS and involves a strand break as a strand discrimination
signal (Kolodner and Marsischky 1999). However, in spite of extensive studies, it remains
unclear how MutS transmits a signal from the mismatch to the strand discrimination signal
and the precise roles played by MutS ATPase activity and the nucleotide-induced
conformational changes of MutS. Two controversial models have been proposed to
explain this process. Here, we tested these models in vitro, using a circular plasmid DNA
substrate with a single GT mismatch and conditional physical 'roadblocks', which when
present, prevent MutSα from sliding bidirectionally along the DNA. Therefore, improved
understanding of the mechanism of MMR is critical to develop tools to selectively kill
MMR-deficient (such as HNPCC) or MMR-proficient cancer cells.

Copyright © Sanghee Lee 2014
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CHAPTER TWO

MATERALS AND METHODS

2-1. Chemicals and Reagents
 Amersham: ECL Detection Reagent




Fisher Biotech: 1-Butanol, Iso-propanol, KH2PO4 (Potassium Phosphate
Monobasic), K2HPO4 (Potassium Phosphate Dibasic), KAcNaH2PO4 (Sodium
Phosphate Monobasic), KOH (Potassium Hydroxide -pellets), NaOH (Sodium
Hydroxide), Na2HPO4 (Sodium Phosphate Dibasic), Na3C6H5O7·2H2O (Sodium
Citrate), P.E.G.-8000 (Polyehylene Glycol), SDS (Sodium Dodecyl Dulfate),
Sodium Bisulfate, Tween-20.
Gibco: FBS (Fetal Bovine Serum)



New England Biolab: Restriction enzymes



MP Biomedicals: bis-acrylamide (N,N'-Methylene-bis-acrylamide)



Perkin Elmer: [γ-32P]-ATP, [α-32P]-ATP



Research Products International Corp: Agar, Boric Acid, CsCl (Cesium Chloride),
Glycerol, Glycine, HEPES (Free Acid), LB Broth, 2x YT Broth, CH3COOK
(Potassium Acetate), Urea



Roche: ATP (Adenosine Triphosphate), ATPγS (Adenosine-5'-O-(3-thio
triphosphate)), dNTPs (deoxy Nucleotides triphosphate), DTT (Dithiothreitol),
NP-40 (Nonidet P-40), Superdex G25 column, Protein G-agarose beads, Fugene HD
transfection reagent



Sigma: Acrylamide, Aphidicolin, D-(+)-Glucose, MgCl2 (Magnesium Chloride),
NaCl (Sodium Chloride), KCl (Potassium Chloride), PVP (Polyvinylpyrrolidone),
Tris (Trizma-base)



USB: Agarose, Ammonium Sulfate, Ammonium Persulfate, Exonuclease V (Exo
V), EDTA, Ethidium Bromide, Glycine, Heparin, Immidazole, T4-PNK, Phenol,
Sucrose.



USBiological: TNM-FH medium



Santa Cruz: MSH2, and Tubulin antibodies



BD Pharmigen: MLH1 and PMS2 antibodies



Bethyl: MSH6 antibody
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2-2. Agarose Gel Eletrophoresis
Agarose gel (1% agarose in 1x TAE) electrophoresis was performed in 1x TAE (40 mM
Tris-Acetate, pH 8.5, 2 mM EDTA) (Johnson and Grossman 1977). DNA samples were
prepared by adding 10x agarose gel loading buffer containing 40% (w/v) sucrose, 0.05%
(w/v) bromophenol blue, 0.05% (w/v) xylene cyanol, 20 mM EDTA, and 0.2% SDS. Gels
were stained for 30 min in 0.5 μg/mL ethidium bromide (EtBr) and destained for 20 min in
ddH2O. DNA fragments were visualized on an ultraviolet (UV) transilluminator and gel
images were captured using a Kodak Image Gel Logic 112 system.

2-3. ATPase activity Analysis
3000 Ci/mmol [γ-32P]-ATP was purchased from PerkinElmer. ATPase activity of
MutSα was analyzed in 20 µL reactions containing 30 Ci/mmol [γ-32P]-ATP, 1.0 µg protein
and 100 ng of mismatch-contained DNA substrates in 25 mM Hepes-KOH (pH 7.6), 4 mM
MgCl2. After incubation at 37°C for 10 min, the reactions were terminated by adding 2x
SSCP(Single-Strand Conformation Polymorphism) loading buffer containing 95% (v/v)
formamide, 0.05% (v/v) bromophnol blue, 0.05% (v/v) xylene cyanol, and 20 mM EDTA. 5
µL samples were loaded and fractionated through a 20% denaturing polyacrylamide gel
(Acrylamide:bis-acrylamide 19:1) in 1x TBE buffer (8.9 mM Tris-HCl, 8.9 mM boric acid,
and 0.2 mM EDTA). Dried gels were visualized and quantified using a Typhoon
PhosphorImager.

2-4. Buffer Preparation
All solutions and cell culture media were prepared in double-distilled water (ddH2O).
Solutions were sterilized either by autoclaving at 121ºC for 30 min or by passage through a
0.22 μM filter.

2-5. Cell Culture
High-Five insect cells were purchased from Invitrogen. The cells were grown in
monolayer culture at 25ºC in TNM-FH medium (pH 6.2) with 10% heat-inactivated FBS
(incubated at 56ºC for 30 min and then on ice for 30 min). Sloughing or tapping the flask
using moderate force dislodged cells. Since High-Five insect cells doubled in less than 24
hours and provide higher expression level than Sf9 insect cells, High-Five insect cells were
used for expressing mismatch repair proteins.
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2-6. Electrophoretic Mobility Shift Assay (Gel Shift Assay)
DNA oliogonucleotides were synthesized by Integrated DNA Technologies (IDT).
Linearized heteroduplex (100 bp) was generated by annealing two complementary 100-mer
synthetic oligonucleotides, which form a single G·T mismatch at position 52.
A:5’-GTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCC
CGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGAATTG-3’
B:5’-CAATTCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGT
GGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGTGCGCGTAACCACCAC-3’
The "A" oligomer was radiolabeled with [γ-32P]-ATP (3000 Ci/mmol, PerkinElmer)
using T4 Polynucleotide kinase in buffer containing 70 mM Tris-HCl (pH 7.6),
10 mM MgCl2, and 5 mM DTT at 37ºC for 1 hr. The reaction was stopped by heating at
75ºC for 10 min. After purification through a Sephadex G25 column (Roche), radiolabeled
oliogonucleotide was annealed to the complementary “B” strand in buffer containing 30
mM HEPES-KOH (pH 7.4), 100 mM KOAc, and 2 mM Mg(OAc)2•4H2O. The reactions
were terminated by heating at 75°C for 10 min and slowly cooled down to room
temperature.
Samples were incubated on ice for 20 min in the presence of 20 mM HEPES (pH 7.5),
40 ug/mL BSA, 2 mM MgCl2, 1 mM DTT, 100 mM KCl, and 8% (w/v) sucrose. Reactions
were terminated by adding 5 µL 50% (w/v) sucrose and analyzed by 6% non-denaturing
polyacrylamide gel in buffer containing 6.7 mM Tris–acetate (pH 7.5) and 1 mM EDTA as
described previously (Gu and Li 2006). 32P-containing species were detected by Typhoon
PhosphorImager.

2-7. Immunoprecipitation Assay
Protein samples were mixed and incubated on ice for 30 min, and diluted antibody was
added. The mixture was then incubated at 4ºC overnight with rotation. 15-30 µL of protein
G- agarose beads (Roche) were prewashed with 50 mM Tris-HCl (pH 7.6), 500 mM NaCl,
and 0.1% NP-40 (washing buffer), added to the protein mixtures and incubated for 1 hr at
4ºC with rotation. Immunoprecipitates were recovered by centrifugation at 100 x g at 4ºC
for 2 min. The supernatant was removed, and the pellet was washed with washing buffer
three times. Precipitated protein was resuspended in 6x protein loading buffer containing
125 mM Tris-HCl (pH 6.8), 2% SDS, 20% glycerol, 0.2% bromophenol blue and heated at
90ºC for 5 min and loaded onto the gel. SDS-PAGE was performed at 150 V in running
buffer containing 2.5 mM Tris, 0.2 M glycine, and 0.1% SDS.
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2-8. In vitro MMR Assay and Excision Assay
2-8-a. In vitro MMR Assay
The in vitro MMR assay was performed as described previously (Holmes, Clark et al.
1990) in a 20 µL reaction containing 30 fmol heteroduplex DNA substrate, 110 mM KCl, 75
μg nuclear extract (HeLa, N6, or H6) or purified proteins (if required), 10 mM Tris-HCl (pH
7.6), 5 mM MgCl2, 1.5 mM ATP, 1 mM Glutathione, 50 μg/mL BSA, and 0.1 mM dNTPs.
The heteroduplex DNA substrate contains a mismatch and a strand break which is located at
5’ side of the mismatch. Reactions were incubated at 37ºC for 20 min, followed by addition
of 30 µL of a proteinase K (PK) solution containing 2.5 mM Tris-HCl (pH 7.5), 5 mM
CaCl2, 12.5% (v/v) glycerol, 6.7% SDS, 25 mM EDTA, and 5 mg/mL proteinase K. PK
digestion was performed at 37ºC for 20 min, and DNA samples were recovered by phenol
extraction twice. DNA was precipitated by addition of 1/10 volume 3 M sodium acetate
(NaOAc, pH 5.5) and 2.5 volume of 100% ethanol and incubated at 80ºC for 15 min. DNA
was pelleted by centrifugation at 14,000 x g at 4ºC for 15 min, and washed with 500 mL
70% ethanol, followed by centrifugation at 14,000 x g at room temperature for 5 min. The
precipitated DNA pellet was dried by speed vacuum centrifugation and then suspended in
10 µL ddH2O. The DNA samples were then incubated with NsiI and BseRI, and cleavage
products were separated by 1% agarose gel electrophoresis and visualized by ethidium
bromide staining with UV. Typical MMR reaction products include linear dsDNA
heteroduplex (7.6 kb) (resistant to restriction enzyme cleavage) and linear homoduplex
fragments 4.2 kb and 3.4 kb in length, corresponding to restriction enzyme-cleavage
products of correctly repaired DNA.

2-8-b. Excision and Southern Blot Assay
The excision assay was described previously (Holmes, Clark et al. 1990) and was
identical to the MMR assay, except that 0.1 mM of dNTPs were omitted to inhibit DNA
synthesis. The assay was carried out in 20 µL containing 30 fmol DNA heteroduplex, 110
mM KCl, 75 μg nuclear extract (HeLa, N6, or H6) or purified proteins (if required), 10 mM
Tris-HCl (pH 7.6), 5 mM MgCl2, 1.5 mM ATP, 1 mM Glutathione, and 50 μg/mL BSA.
Reactions were incubated at 37ºC for 10 min, followed by addition of 30 µL PK solution.
The mixtures were incubated at 37ºC for 20 min and DNA was recovered by phenol
extraction followed by ethanol precipitation (described above). DNA was resuspended in 10
µL ddH2O, incubated with PstI and BglI to score excision products (Figure 2.1.B).
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DNA excision intermediates were analyzed using by Southern blot, essentially as
described previously (McCulloch, Gu et al. 2003). After digestion with PstI and BglI, the
reactions were terminated by addition of 2x SSCP (95% formamide, 0.05% bromophnol
blue, 0.05% xylene cyanol, and 20 mM EDTA) and heated at 90ºC for 10 min. The excision
products were analyzed on a 6% Urea-polyacrylamide denaturing gel (10 g of urea, 3 mL of
40% Acr:Bis (19:1), 3 mL of 10x TBE, 155 µL of 10% APS, 14 µL of TEMED, and 8 mL of
distilled water). The gel was pre–run in 1x TBE buffer containing 89 mM Tris-HCl, 89 mM
boric acid, and 2 mM EDTA at 16 W for 30 min prior to sample loading (Johnson and
Grossman 1977) and run at 8 W for 2 h after sample loading. The gel was transferred to
nylon membrane (GE healthcare) in 1x TBE buffer using a Hoefer electrotransfer apparatus
at 1 A (38 V) for 1 hr at 4°C. After the electrotransfer, the membrane was air-dried for 10
min and DNA was UV-crosslinked to the membrane for 7 min. The membrane was
prehybridized in 50 mM Tris-HCl (pH 7.5), 1 M NaCl, 2% SDS, 1 mM EDTA, 0.5%
polyvinylpyrrolidone, and 0.2% heparin and then hybridized at 37ºC overnight in 10 mL of
the same buffer containing a 32P-labeled oligonucleotide that hybridizes adjacent to the PstI
site in the DNA substrate. The membrane was washed twice with 2x SSC buffer (2x SSC +
0.1% SDS, 20x SSC: 3 M NaCl + 0.3 M Sodium Citrate, pH 7.0) and twice with 1x SSC
buffer (1x SSC + 0.1% SDS). Reaction products were visualized by autoradiography.
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A.

B.

Figure 2.1 Principle of in vitro mismatch repair and excision assay.
(A) In vitro MMR assay. Heteroduplex DNA substrates contain a G-T mismatch within the
overlapping recognition sites for NsiI and XhoI and a strand break 5’ to the mismatch. The
heteroduplex DNA substrate is incubated with HeLa nuclear extract or purified MMR
proteins. Products of nick-directed specific DNA repair are susceptible to cleavage by NsiI,
but the non-repaired DNA substrate is not. Thus, 3.4 kb and 4.2 kb Nsi/BseRI cleavage
fragments reflect correct repair, while a 7.6 kb DNA fragment reflects lack of repair.
(B) In vitro excision assay. Excision assay was performed was performed essentially same
as repair assay except omitting exogenous dNTPs to inhibit DNA resynthesis. The reaction
products were subjected to cleavage with PstI and BglI and then analyzed by Southern blot
using a probe complementary to the PstI site sequence (yellow bar).

23

2-9. Nuclear Extract Preparation
Hela-S3 cells and N6 cells were cultured in RPMI-1640 containing 10% Fetal Bovine
Serum (FBS) and DMEM containing 10% FBS, respectively. Nuclear extracts were
prepared on ice or at 4ºC, as described previously (Holmes, Clark et al. 1990). Protease
inhibitor cocktail (0.1% PMSF, 1 µg/mL leupeptin, 1 µg/mL pepstain A) was added to all
solutions. Cultured cells were harvested by centrifugation at 3,000 x g for 10 min in an
H-6000A rotor. The supernatant was discarded, and the cell pellet was resuspended in wash
buffer containing 20 mM Hepes-KOH (pH 7.5), 5 mM KCl, 0.5 mM MgCl2, 0.2 M Sucrose,
0.5 mM DTT, followed by centrifugation at 3,300 x g for 5 min. Cells were resuspended in
hypotonic buffer (2.78 ml/g of cells) including 20 mM Hepes-KOH (pH 7.5), 5 mM KCl,
0.5 mM MgCl2, 0.5 mM DTT and incubated on ice for 10 min. Swollen cells were disrupted
by using a dounce homogenizer on ice to obtain intact nuclei (about 10 to 15 strokes with
the B pestle). Cell nuclei were then collected by centrifugation at 2,000 x g, using the
Beckman Coulter JA-20 rotor. The cell nuclei pellet was resuspended in extraction buffer
(1.39 ml/g cells) containing 20 mM Hepes-KOH (pH 7.5), 5 mM KCl, 0.5 mM MgCl2, 10%
(w/v) sucrose, 0.5 mM DTT, followed by addition of 0.031 volumes of 5 M NaCl. Nuclear
proteins were extracted by incubation of the resuspended nuclei on a rotating rack for 60
min at 4ºC. After centrifugation at 14,500 x g for 20 min, the nuclear debris was discarded,
and the supernatant was collected. 0.42 g/ml of ammonium sulfate was added to the
supernatant to precipitate nuclear proteins, and the mixture was slowly stirred on ice for 20
min. Precipitated proteins were pelleted by centrifugation at 15,800 x g for 20 min. The
supernatant was completely removed and the protein pellet was resuspended in dialysis
buffer (~90 µl) including 20 mM Hepes-KOH (pH 7.6), 50 mM KCl, 2 mM DTT, 0.1 mM
EDTA. The slurry was transferred to a dialysis bag, and the mixture was dialyzed until
conductivity of the sample reached 50 μS/cm (10 μl sample/4 ml ddH2O). Dialyzed extract
was clarified by centrifugation at 16,000 x g for 15 min at 4ºC. Aliquots of 30 to 50 µl were
frozen by adding them to liquid nitrogen and stored at -80ºC until use. Protein
concentrations were measured by the Bradford method (Ausubel and Gitler 1987).

2-10. Nucleotide Binding Analysis
Nucleotide binding was analyzed as described previously (Mazur, Mendillo et al. 2006)
with minor modifications. 3000 Ci/mmol [γ-32P]-ATP and 3000 Ci/mmol [α-32P]-ATP were
purchased from PerkinElmer. Reactions were performed in 20 µL containing 50 mM
Tris-HCl (pH 7.8), 110 mM NaCl, 2 mM DTT, 100 mg/mL BSA, 0.5 mM EDTA, 5%
glycerol, with or without 5 mM MgCl2. Non-radiolabled 1 μM DNA containing a mismatch
was added 10 min prior to addition of nucleotide. 1 µg purified MutSα was mixed with [γ or
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α-32P]-ATP and incubated on ice for 20 min. Samples were then subjected to 7 min of
crosslinking (UVP Crosslinkers) and immediately heated at 90ºC for 5 min after adding 6x
protein loading buffer containing 125 mM Tris-HCl (pH 6.8), 2% SDS, 20% glycerol, 0.2%
bromophenol blue, which was fractionated by 10% SDS-PAGE gel. Gels were dried by
vacuum (BioRad gel dryer) at 80ºC for 1 hr and quantified using a Typhoon
PhosphorImager.

2-11. Preparation of DNA Substrate
2-11-a. Preparation of Bacteriophage Stock
The M13mp18-GC and M13mp18-AT phage were derived from M13mp18 parental
DNA (New England Biolab) as described previously (They were called M13mp18-UKY1
and M13mp18-UKY2) (Su, Lahue et al. 1988). Phage DNA (10-100 ng) was added to 50
µL XL-1 Blue competent cells (Strategene) and then placed on ice for 30 min. The mixtures
were heated at 42ºC for 45 sec, followed by incubation on ice for 2 min. 0.5 mL SOC media
(0.5% Yeast Extract, 2% Tryptone, 10 mM NaCl, 2.5 mM MgCl2, 10 mM MgSO4, 20 mM
Glucose) was added to the transformed cells and then grown at 37ºC for 1 hr with shaking at
180 rpm. 30 µL of transformed cells was mixed well with 3 mL pre-warmed 2x YT soft agar
(0.6% agar) containing 200 µL of fresh overnight-cultured XL-1 Blue cells. The mixture
was spread on LB plates, and the plates were incubated at 37ºC for overnight. Individual
plaques were picked and inoculated into 3 mL 2x YT containing 3 µL tetracycline (Tet) and
30 µL overnight-cultured XL-1 Blue cells and cultured at 37ºC for 6 hr with shaking at 250
rpm. Cells were harvested by centrifugation at 12, 000 x g for 10 min at 4°C to isolate DNA,
and the supernatant was collected and stored at 4ºC for phage stock. For large scale
preparation of phage stock, 50 mL 2x YT containing 50 µL Tet and 1 mL
overnight-cultured XL-1 Blue cells was incubated at 37ºC for 90-120 min with shaking at
250 rpm until OD590 reached 0.3, and then 500 µL phage stock was added. The culture was
incubated with shaking at 37ºC for 6 to 8 hr, and cells were centrifuged at 10,000 x g for 10
min. The cell pellet was removed and the supernatant was saved as phage stock.

2-11-b. Preparation of dsDNA and ssDNA
20 mL of an overnight-cultured of XL-1 Blue cells was inoculated into 3 L 2x YT and
the cell culture was grown at 37ºC in a shaking incubator for approximately 2.5 hr until
OD590 reached 0.3. Phage stock (0.8 mL) was then added to the 3 L culture and it was
incubated with continuous shaking at 250 rpm at 37ºC for 8 h. The culture was allowed to
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cool down for 20 min and then cells were harvested by centrifugation at 4,500 x g for 10 min
at 4ºC. The supernatant was kept for ssDNA preparation. The cell pellet was resuspended in
120 mL ice-cold solution I containing 25 mM Tris-HCl (pH 8.0), 10 mM EDTA, 0.9%
(w/v) sucrose and 5 mg/mL lysozyme and incubated at room temperature for 10 min. 240
mL freshly prepared solution II (0.2 N NaOH and 1% SDS) was added, gently mixed, and
incubated on ice for 10 min. 180 mL ice-cold solution III including 3 M potassium acetate
and 2 M acetic acid was mixed with the lysed cell solution and placed on ice for 10 min. The
supernatant was separated from protein debris by centrifugation at 12,000 x g at 4ºC for 60
min and filtered through 4 layers of cheesecloth. After measuring the volume of the
supernatant, 0.6 volume isopropanol was added, and the mixture was mixed vigorously. The
mixture was incubated at -20ºC for 15 min and followed by centrifugation at 16,000 x g at
4ºC for 30 min to precipitate DNA. The supernatant was discarded, and the pellet was
washed with 100 mL 70% ice-cold ethanol. The pellet was air-dried and dissolved in 20 mL
1x TE (pH 8.0) containing 10 mM Tris-HCl pH 8.0, 1 mM EDTA. The solution was
weighed and mixed with CsCl (1.1 g/g solution) and 10 mg/mL EtBr (50 μl/g solution)
according to the solution weight. All procedures were performed in the dark. The CsCl and
EtBr-mixtured DNA was transferred to an ultracentrifuge tube, and tubes were placed in a
Beckman NVT65 rotor. Samples were spun at 45,000 rpm for 16-18 hr at 25ºC. The band of
supercoiled DNA was located near to the middle of the tube (nicked DNA is located above
the supercoiled DNA) and was removed from the tube using a syringe with a needle.
Ethidium bromide was removed from the DNA by extraction with 1 vol water-saturated
n-butanol. The aqueous solution containing supercoiled DNA was then dialyzed in TE
buffer (pH 8.0). DNA concentration was measured by UV absorption at 260 and 280 nm.
Phage particles were precipitated from the culture supernatant by adding 36 g NaCl/L
and 50 g PEG-8000/L of the supernatant. The solution was stirred at room temperature for 1
hr, followed by centrifugation at 5,500 x g at 4ºC for 30 min. The pellet was suspended in 22
mL TE buffer, incubated for 1 hr at 37ºC with shaking at 150 rpm, and then centrifuged for
10 min at 14,500 x g at 4ºC. The pellet was discarded, and the supernatant volume was
mesured. Phage particles were concentrated by CsCl (0.4342g CsCl/g phage solution)
equilibrium centrifugation using the same conditions for dsDNA isolation. The band of
phage particles was collected from the centrifuge tube by using a syringe with a needle, and
dialyzed against 500 mL TE buffer (10 mM Tris, pH 7.6 and 1 mM EDTA). The buffer was
changed at least three times every 6-8 hrs. Single-stranded DNA (ssDNA) was isolated from
phage particles by extraction with TE-balanced phenol (3 times) and ethylether (2 times).
The extractions were followed by centrifugation at 12,000 x g for 5 min at 25ºC. After the
last ether extraction, the trace of ether remaining in the solutions was evaporated by
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incubation at 37ºC for 10 to 30 min. The solution was then dialyzed as described for dsDNA
isolation. The DNA concentration was measured by UV absorption at 260 nm.

2-11-c. Preparation of circular heteroduplex substrates
To construct a plasmid DNA substrate containing Lac repressor binding sites, Lac
repressor binding sequence was inserted into HindIII restriction enzyme site of M13mp18
dsDNA (Figure 2.3). A mismatch and a ssDNA break (nick) 5’ to the mismatch was
introduced by denaturing linear dsDNA (GC) and annealing it with circular ssDNA (T)
containing one base difference within the complementary sequences (Figure 2.2.C) (Su,
Lahue et al. 1988). For this purpose, dsDNA digested with BglI and the ssDNA were mixed
with a 5-fold excess of circular ssDNA relative to dsDNA in 30 ml reaction containing 50
mM Tris-HCl (pH 7.6), 100 mM NaCl, 1 mM EDTA, which was adjusted to 0.3 N NaOH
(900 µL of 10 N NaOH). The mixture was incubated at room temperature for 5 min and then
added to 3 mL of 2.9 N acetic acid, 1.35 mL of 3 M KCl, and 3.7 mL of 1 M Na-Pi (pH7.4).
The reaction was incubated at 65ºC for 30 min, slowly cooled down to 37ºC for 5 hr, and
then incubated for 30 min at 37ºC. The solution was placed on ice. The efficiency of
annealing was determined by analysis of pre- and post-annealing mixtures (100 ng) using
0.8% agarose gel electrophoresis. (Nicked hetetroduplex migrates more slowly than linear
dsDNA and ssDNA.)
Annealing reaction products were applied to Hydroxyapatite (HAP) resin (8 g HAP
resin, 1-1.2 g/mg of total DNA) pre-washed and pre-equilibrated at a flow rate of 1-1.3
volume/hr with 30 mM Na-Pi (pH 6.9). The HAP column was washed sequentially with 30
mM Na-Pi (pH 6.9), 160 mM Na-Pi (pH 6.9) (160 drops, 5 ml/tube), and 420 mM Na-Pi
(pH 6.9) (40 drops, 1.25 ml/tube) to elute ssDNA and dsDNA respectively (Figure 2.2.D).
Aliquots (3 µL) of fractions eluted by 420 mM Na-Pi (pH6.9) were mixed with 7 µL EtBr (1
μg/mL), placed on plastic wrap, and illuminated with shortwave UV (Fisher Sicentific) to
estimate DNA content. Fractions with higher DNA concentration were pooled,
concentrated 3- to 4-fold by n-butanol extraction, and dialyzed against 500 mL TE buffer
(pH 7.6) at 4 ºC with 3 buffer changes over approximately 24 h. The DNA concentration
was measured by UV absorbance at 260 nm.
Nick-contained circular heteroduplex DNA was separated from linearized homoduplex
by digestion with E. coli Exonuclease V (ExoV) (USB) (Figure 2.2.E) in buffer containing
66.7 mM glycine (pH 9.4), 5 mM MgCl2, 8.3 mM β-mercaptoethanol (β-ME), 0.5 mM
adenosine triphospate (ATP) and 0.2 U/µL Exo V (10 U/μl) at 37ºC for 3 h. During the
ExoV digestion (after about 1 hr digestion), pre- and post- ExoV digested DNA samples
were taken out to analyze by a 1.0% agarose gel electrophoresis. In the ExoV-digested
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product, the linear dsDNA, which migrates faster than the circular heteroduplex would be
disappeared. In case of that traces of the linear dsDNA could be observed, ExoV digestion
should be continuously incubated at 37ºC until the linear dsDNA was undetectable. The
reaction was extracted once with phenol, concentrated to 1.0 mL by n-butanol extraction,
and exchanged into TE buffer by dialysis.
Olimomers and nucleotides were removed by Sephacryl S500 column chromatography
(Pharmacia) equilibrated with TE with 0.3 M NaCl (pH 7.6) at a flow rate of 10-15 mL/hr
(40 drops, 1ml/tube). Aliquots (3 µL) of fractions were mixed with 7 µL EtBr (1 μg/mL),
placed on plastic wrap, and illuminated with shortwave UV (Fisher Sicentific) to estimate
DNA content. The purity of the substrate was checked by 1% agarose gel electrophoresis,
and fractions with higher DNA concentration were pooled. The DNA substrate was
concentrated by n-butanol extraction and exchanged into TE (pH 7.6) buffer by dialysis.
The concentration of the DNA was measured by UV absorbance at 260 nm.
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Figure 2.2 Preparation of 5’ nicked G-T mismatch substrate.
(A) Circular homoduplex M13mp18-GC dsDNA (blue) was linearized with BglI (V= viral
strand; C= complementary strand). (B) Linear dsDNA was denatured and annealed in the
presence of excess circular M13mp18-AT ssDNA (red). (C) Reaction products include
nicked circular heteroduplex, circular ssDNA, linear dsDNA and linear ssDNA. (D)
Hydroxyapatite column was used to separate dsDNA from ssDNA. (E) Linear homoduplex
dsDNA was digested with E. coli Exo V into 1-5 nucleotide fragments, which were
separated from circular heteroduplex dsDNA by Sephacryl S500 size exclusion
chromatography.
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Figure 2.3 Schematic representations of 5’ nicked G-T heteroduplex substrates
containing two Lac repressor-binding sites.
5’ nicked G-T heteroduplex substrate used for in vitro MMR assay was derived from
M13mp18 phage. It was constructed to contain a mismatch, a strand break (a strand
discrimination signal) and two Lac repressor-binding sites. A mismatch is located within the
overlapping recognition sites for two restriction enzyme sites, NsiI and XhoI.

2-12. Purification of Lac repressor and Nuclease activity Assay
The gene encoding Lac repressor was cloned into the EcoR I site of pBR322 (Chen and
Matthews 1992, Falcon, Swint-Kruse et al. 1997, Glascock and Weickert 1998,
Swint-Kruse, Zhan et al. 2003) and the resulting plasmid was transformed into E.coli BLIM
cells. After transformation, cells were cultured in LB overnight at 37ºC with shaking and
then harvested by centrifugation. The pellets were dissolved in lysis buffer (0.2 M Tris-HCl
(pH 7.6), 0.2 M KCl, 0.01 M MgAC2, 0.3 mM DTT, 5% glucose, 50 μg/L PMSF) plus 0.5
mg/mL lysozyme. Cell debris was removed by centrifugation, the supernatant was
recovered, and proteins were precipitated by addition of 40% Ammonium Sulfate (Figure
2.4.A). Samples were incubated at 4ºC for 1 hr, protein pellets recovered by centrifugation,
pellets resuspended in dialysis buffer containing 0.05 M Potassium phosphate (pH 7.5), 0.3
mM DTT, 5% glucose and dialyzed overnight at 4ºC. The dialyzed protein was passed
through a 5 mL heparin column (GE Healthcare) pre-equilibrated with 20% buffer D (1 M
NaCl, 25 mM Hepes (pH 7.8), 1 mM EDTA, 2 mM DTT, 1x protease inhibitor cocktail).
The column was washed with 6 column volume of 20% buffer D and eluted with a gradient
of 20-75% buffer D. Fractions containing Lac repressor were identified by SDS-PAGE
(Figure 2.4.B), and pooled fractions were concentrated to 1 mL using a centrifugal filter
spin column (Amicon Ultra Centrifugal Filters). The concentrated protein was further
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purified by SuperdexTM 200 Gel filtration column (GE healthcare) in 15% of buffer D.
Fractions containing Lac repressor were identified by SDS-PAGE and pooled (Figure
2.4.C), and protein concentration was measured by Bradford assay. To store the purified
protein, 1 mg/mL bovine serum albumin (BSA) and 10% sucrose were added to stablize the
protein in freezing and thawing process. The proteins were dispensed into aliquots, frozen in
liquid nitrogen and stored at -80°C until use.

A.

B.

C.

Figure 2.4 Purification of Lac repressor.
Red rectangle indicates Lac repressor. (A) Cell lysate precipitated by 40% Ammonium
Sulfate. (B) Lac repressor purified via heparin column, which is used for purification of
DNA binding protein. (C) Lac repressor purified through S200 Gel Filtration column. All
steps after the purification were analyzed by 10-12% SDS-PAGE.

To test contaminating nuclease activity of the purified protein, protein samples were
incubated with 30 bp of 5'- 32P-labeled dsDNA in buffer containing 125 mM Tris-HCl (pH
7.6), 25 mM MgCl2, 0.5 mg/mL BSA, 50% glycerol, and 10 μM DTT. Reaction products
were separated by denaturing 20% PAGE (12.5 g of Urea, 12.5 ml of 40% Acr/Bis (19:1),
2.5 ml of 10x TBE, 190 μl of 10% APS, and 13μl of TEMED).

2-13. Purification of MutSα, MutSβ, and MutLα from High-Five insect cells
Baculovirus stocks for overexpression of human MSH2 and MSH6 were generous gifts
of Dr. Josef Jiricny (University of Zurich). These reagents are based on the Bac-to-Bac
expression system (Invitrogen), which was used to express and purify MutSα protein
subunits according to the manufacturer's instructions. The pFastbac1 plasmids encoding
MSH2, and MSH6his were transformed into DH10-Bac E. coli cells and positive colonies
were identified by PCR. High Five insect cells were purchased from Invitrogen and cultured
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in TNM-FH medium (US biological) including 10% FBS (Gibco). Bacmids bearing
encoding MSH2 or MSH6his were transfected into High-Five insect cells using Fugene HD
transfection reagent in 6 well plates. The virus-inoculated insect cells were cultured for
48-72 hr and collected by centrifugation at 1,200 x g for 5 min, followed by washing in PBS.
The baculovirus stock was amplified and used to inoculate 60-80% confluent insect cells in
10 dishes of 150 cm2. Infected cells were incubated for 48 hr, collected by centrifugation at
1,200 x g for 5 min, washed once with PBS and centrifuged at 1,200 x g for 5 min. Pellets
were resuspended in buffer A (5 mL/g) containing 20 mM Imidazole, 25 mM Hepes-KOH
(pH 7.8), 2 mM DTT, 300 mM NaCl, 10% (v/v) glycerol, and 1x protease inhibitor cocktail
and then disrupted using a Dounce homogenizer (10 to 12 strokes). The homogenized cells
were then sonicated 10X for 15 seconds at 15 sec intervals, using a Fisher Scientific
sonicator at 30-40% strength. Cell debris was removed by centrifugation at 20,000 x g for 1
hr at 4ºC using the Beckman Coulter JA-20 rotor. The supernatant was collected and loaded
onto a 5 mL His-tag Nickel column (GE Healthcare) pre-equilibrated with buffer A. The
column was washed with 8 column volume of 100% buffer A and then eluted with a
gradient of 0-80% buffer B (500 mM Imidazole, 25 mM Hepes-KOH (pH 7.8), 2 mM DTT,
300 mM NaCl, 10% (v/v) glycerol, and 1x protease inhibitor cocktail). Peak fractions were
identified by SDS-PAGE, pooled and diluted with buffer C (25 mM Hepes (pH 7.8), 1 mM
EDTA, 2 mM DTT, and 1x protease inhibitor cocktail) to a conductivity equivalent 150 mM
KCl. The pooled protein was loaded onto a 1 mL Mono Q column (GE healthcare)
pre-equilibrated with 15% buffer D containing 1 M NaCl, 25 mM Hepes (pH 7.8), 1 mM
EDTA, 2 mM DTT, and 1x protease inhibitor cocktail. The column-bound protein was
washed with 10 column volume of 15% buffer D and eluted with 15-70% buffer D. Peak
fractions were pooled, concentrated to 1 mL, using a centrifugal filter spin column (Amicon
Ultra Centrifugal Filters) at 5,000 rpm. The concentrated protein was then loaded onto
25mL SuperdexTM 200 Gel Filtration (GE healthcare) and eluted with 15% buffer D. Peak
protein fractions were detected by SDS-PAGE, protein concentration was measured by
Bradford assay, adjusted to 1 mg/mL bovine serum albumin (BSA) and 10% sucrose, and
divided into aliquots, which were frozen in liquid nitrogen and stored at -80°C until use.

2-14. SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE gels were prepared using a 30% acrylamide stock solution
(acrylamide:bis-acrylamide=30%:0.8%) (Okajima, Tanabe et al. 1993). Protein samples
were mixed with 6x protein loading buffer containing 125 mM Tris-HCl (pH 6.8), 2% SDS,
20% glycerol, 0.2% bromophenol blue, followed by heating at 90ºC for 5 min. SDS-PAGE
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was performed at 150 V in the buffer containing 2.5 mM Tris, 0.2 M glycine, and 0.1%
SDS.

2-15. Site-directed Mutagenesis
Site-directed mutagenesis, which was used to make point mutations, switch amino
acids, and delete or insert single or multiple amino acids, was performed as described
previously (Kirsch 1987, Kirsch and Joly 1998). Briefly, primers for PCR were constructed
by using QuikChange primer design program through Agilent Technologies website.
Parental DNA was amplified by PCR using the designed primers and high fidelity DNA
polymerase. The amplified products were treated with Dpn I to cleave methylated GmATC
sites in parental DNA, sparing newly synthesized DNA containing site-directed mutations.
Dpn I-digested product was transformed into XL-1 Blue or DH5α cells by heat-shock.
Positive colonies were selected and cultured in LB containing 100 μg/mL of ampicilin.
DNA was isolated from individual colonies and screened by PCR and sequencing.

2-16. Transfections into the Insect cells
Transfections into insect cells were performed using the Fugene HD transfection
reagent. DNA was diluted in 100 μl of serum-free medium with appropriate diluents
(around 1-2 μg). Fugene HD reagent was directly added into the diluted DNA with 3:1 ratio
(3 μl Fugene HD reagent: 1-2 μg DNA) and mixed vigorously by either tapping or
vortexing. The mixture was incubated at room temperature for 30 min to allow complex
formation and then added into the 60 to 80% confluence cell cultures in 6-well plates.
Transfection was performed based on Fugene HD protocol.

2-17. Transformations of Competent Cells
Frozen aliquots of 50 µL competent cells (E.coli XL-1 Blue or DH5α, or DH10 Bac)
were thawed on ice. DNA (100 to 500 ng) was added to the competent cells and incubated
on ice for 30 min. The DNA-cell mixture was heated at 42ºC for 45 sec, followed by
incubation on ice for 2 min (Mandel and Higa 1970). Then, 0.5 mL of SOC (or LB or 2x
YT) was added and cells were incubated for 1 hr at 37ºC with shaking at 200 rpm.
Transformed cells were spread on LB plates containing selective antibiotic and the plates
were incubated overnight at 37ºC.
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2-18. Western Blot Analysis
50 µg whole lysates or nuclear extract or 1 µg purified-protein was fractionated by
8~15% SDS-PAGE. Proteins were transferred onto nitrocellulose membrane using a
BioRad electrotransfer device for 1 hr at 400 mA in transfer buffer (3.03 g Tris, 14.4 g
glycine/L, and 200 ml/L methanol) (Renart, Reiser et al. 1979, Towbin, Staehelin et al.
1979, Okajima, Tanabe et al. 1993). The nitrocellulose membrane was blocked in 5% nonfat
dry milk and TBS-T (10 mM Tris-HCl (pH 7.5), 0.8% NaCl, 0.1% (v/v) Tween 20) for 1 h
at room temperature. The membrane was incubated overnight with the same solution
containing primary antibody (1:1000 dilution in 5% nonfat dry milk). The blot was washed
3X for 5 min in TBS-T, incubated at room temperature for 1-3 hr with secondary antibody
conjugated with horseradish peroxidase (Sigma) diluted in the same buffer. The membrane
was washed 3X for 5 min with TBS-T at room temperature, and proteins were detected
using ECL detection reagents (Roche) and autoradiography.

Copyright © Sanghee Lee 2014
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CHAPTER THREE
SLIDING OF MUTSα TO COMMUNICATE WITH A STRAND BREAK IS NOT
ESSENTIAL FOR THE INITIATION OF MISMATCH REPAIR.

INTRODUCTION
Mismatch repair (MMR) is mainly responsible for improving replication fidelity by
reducing the spontaneous mutation rates and carcinogenesis, which induces to maintain the
integrity of the whole genome. Defects in human MMR eventually lead to development of
hereditary non-polyposis colorectal cancer (HNPCC) and are also linked to other human
cancers. The mechanism of MMR is highly conserved through evolution, but there are
notable differences in how prokaryotic and eukaryotic MMR discriminate between the
parental and the newly synthesized DNA strands. It has been proposed that eukaryotic
MMR utilizes a strand-specific nick, and is therefore nick-directed, while prokaryotic MMR
utilizes hemi-methylated dGATC sites for this purpose. MutSα, which consists of the
MSH2 and the MSH6 subunits and recognizes a mismatch, initiates human mismatch
repair. Mismatch binding by MutSα triggers a series of downstream mismatch repair
(MMR) reactions including interacting and communicating with other MMR proteins
(Gradia, Acharya et al. 1997, Blackwell, Bjornson et al. 1998). Since eukyryotic EXO1
exhibits only 5′ → 3′ excision, mismatch binding by MutSα activates EXO1-catalyzed
excision directly only when a strand break is located at 5’ side of the mismatch. For the
3’-directed MMR, more MMR proteins such as MutLα, PCNA, and RFC play a role in
formation of a strand break as an initial point of MMR (Zhang, Yuan et al. 2005). However,
in spite of improving effort and progress to identify MMR components over the years, it
remains unknown how MutS facilitates communication between the mismatch and the
strand discrimination signal (the nick) to initiate MMR, and how the MutS ATPase and/or
ATP-dependent conformational changes of MutS contributes to the mechanism of MMR
in human cells. The experiments described in this chapter were designed to provide new
molecular information about the process of strand discrimination during MMR in human
cells.
Several putative models to explain initiation of MMR have been developed and
proposed. Since the entry point, a single-strand break, is positioned several hundred base
pairs away from the mismatch in vivo, identifying how two physically distant sites
communicate each other is essential to understand MMR mechanism. MMR initiation
models are generally classified into “stationary (trans)” or “moving (cis)” models. The
“stationary” model (Figure 1.6 right) proposed that MutSα remains bound at the mismatch,
while interactions of MMR proteins are attributed to DNA bending or looping that brings
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two physical distant sites in proximity (Junop, Obmolova et al. 2001, Guarne,
Ramon-Maiques et al. 2004). This model postulated that ATPase activity of MutS is
required for proofreading mismatch recognition and inducing MutS interactions with
other MMR proteins that trigger downstream signaling of MMR (Wang and Hays 2003,
Wang and Hays 2004). Another proposed model, which is called the “moving” or “cis”, is
based on the movement of MutS along the DNA, but varies in terms of energy requirement
for the movement of MMR proteins along the DNA. There are two ‘moving’ models: One is
translocation model, and the other is sliding model. In translocation model (Figure 1.6 left),
it is proposed that MutS binds to a mismatch in a nucleotide-free state, and ATP binding of
MutS reduces its mismatch-binding affinity. ATP hydrolysis consequently drives
unidirectional translocation of MutS along the DNA away from the mismatch (Allen,
Makhov et al. 1997, Blackwell, Bjornson et al. 1998, Blackwell, Martik et al. 1998).
However, there is no evidence showing that this model is relevant to human MMR. In the
sliding model (Figure 1.6 middle) ADP-bound MutS searches for a mismatch, and
mismatch binding by MutS induces its conformational change and exchange of ADP for
ATP. ATP-bound MutS then forms a “sliding clamp”, which travels along the DNA until
it encounters a strand discrimination signal (Gradia, Acharya et al. 1997, Fishel 1998,
Gradia, Subramanian et al. 1999, Jiang, Bai et al. 2005, Mendillo, Mazur et al. 2005). This
model posits that ATP binding, but not ATP hydrolysis, signals downstream MMR events
including recruitment of MutL to a ternery complex and dissociation of MutS from the
mismatch (Selmane, Schofield et al. 2003).
As described in Chapter 1, there is evidence to support the stationary and the sliding
models for human MMR, but it is not possible at present to rule one of the models in or out.
To provide definitive evidence for or against one model, we developed a specialized DNA
substrate with physical “roadblocks” and used them in an in vitro DNA excision or MMR
assay system. Lac repressor/Lac operator was used as a physical “roadblock” to restrict
sliding window of ATP-bound MutS to the DNA region intervening between two
roadblocks.
The Lac repressor/operator system is well studied, and its role in regulating genetic
expression in bacteria is well understood. In brief, the Lac repressor (Lac I), a high affinity
37 kDa DNA binding protein that exists as a homotetramer (Swint-Kruse, Elam et al. 2001),
is released from the DNA by IPTG (Isopropyl β-D-1-thiogalactopyranoside). In the
experimental system used here, the roadblocks can be turned on by omitting IPTG and
turned off by adding IPTG, a feature used here as a switch to turn MutS sliding off or on,
respectively. Our results demonstrated that restriction of MutSα sliding by presence of dual
physical roadblocks significantly inhibits in vitro MMR, but they do not inhibit
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mismatch-provoked excision. Therefore, the results presented here provide evidence that
MutS sliding is not required during the strand discrimination step of human MMR.
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RESULTS
Purification and functional tests of Lac repressor and MutSα proteins.
The first steps for these experiments was to prepare Lac repressor protein and human
MutSas described in Chapter 2, to characterize the quality of the protein samples and to
test the assumptions inherent in the experimental system. Figure 3.1.A & C show protein gel
analysis of the purified proteins to verify their level of purity and assay of Lac repressor for
contaminating nuclease activity (Figure 3.1.B)
A.

B.

C.

MSH6
MSH2

Figure 3.1 Purification of Lac repressor and MutSα proteins.
(A) Purified Lac repressor analyzed by 12% SDS-PAGE. (35 kDa) (B) Nuclease activity of
purified Lac repressor on 32P-labled linear dsDNA was analyzed by 20% sequencing gel.
(C) Purified MutS analyzed by 10% SDS-PAGE (MSH2: 104.7 kDa, MSH6: 163 kDa).

Figure 3.2 Crystal structure of tetramer Lac repressor and its binding sequence.
Lac repressor is a homotetramer DNA binding protein that recognizes 5’-AATTGT-3’ in
the context of the 20 nucleotides Lac operator 5’-AATTGTGAGCGGATAACAATT-3’.
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To examine the interaction between purified Lac repressor and Lac repressor-binding
site, 198 bp of 32P-labled DNA containing either random sequence or Lac repressor-binding
sequence (Figure 3.2) was used to perform EMSA. As shown in Figure 3.3.A, Lac repressor
binds to DNA containing Lac repressor-binding sequence (lane 4), but not to a nonspecific
DNA oligonucleotide substrate. Another experiment was performed to confirm that IPTG
releases Lac repressor from its binding site (Figure 3.3.A, lane 5). The result showed that
addition of IPTG causes dissociation of most Lac repressor complexes, but some Lac
repressor-DNA complexes persist in the presence of 20 mM IPTG. However, higher
concentration than 20 mM IPTG did not stimulate more complete dissociation of Lac
repressor from its binding site (Figure 3.3.B).
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Figure 3.3 Binding of purified Lac repressor to Lac repressor-binding site and
dissociation of Lac repressor from DNA by induction of IPTG.
(A) Specific interaction of Lac repressor with its binding sequence. Lac repressor (0.7 µM)
was incubated with 0.32 µM 32P-labled DNA substrate and 10x fold excess of nonspecific
competitor DNA (198 bp of 32P-nonlabled DNA composed of random sequence) and
reactions were analyzed by EMSA. (B) EMSA was performed in the presence of increasing
concentration of IPTG. Bands were quantified using Kodak Image Software.
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Sliding of MutSα along the DNA is restricted by Lac repressor roadblock.
EMSA assays were performed to identify if MutSα sliding was prevented by Lac
repressor roadblock. Linear 32P-labeled dsDNA substrate (300bp) containing a G-T
mismatch as well as 5' and 3' flanking Lac repressor-binding sites were pre-incubated with
Lac repressors and then incubated with MutSα in the presence or absence of ATP. As
expected, both Lac repressor and MutSα bind to the DNA substrate (Figure 3.4-lane 2 and
6) and the MutSα-bound DNA band was supershifted in the presence of Lac repressor
(Figure 3.4-lane 4), indicating that both Lac repressor and MutSα can bind to a single DNA
molecule. Furthermore, binding of Lac repressor was ATP-independent (Figure 3.4-lane 3),
while binding of MutSα was ATP-dependent (Figure 3.4, lane 7). Because MutSα can
dissociate from the mismatch and slide along the DNA in the presence of ATP but not in its
absence, or in the presence of ADP, the complex between MutSα and the DNA is reduced in
amount or absent in the presence of ATP (Figure 3.4-lane 7). This is consistent with the idea
that ATP-bound MutSα diffuses away from a mismatch (Gradia, Acharya et al. 1997,
Gradia, Subramanian et al. 1999, Wilson, Guerrette et al. 1999, Acharya, Foster et al. 2003,
Mendillo, Mazur et al. 2005) and falls off the end of a linear DNA substrate. As predicted,
the supershifted DNA-protein complex containing MutSα and Lac repressor remained
supershifted and did not dissociate from the DNA in the presence of ATP (Figure 3.4-lane
5). This indicates that the Lac repressor roadblock lying between the mismatch and each end
of the linear dsDNA restricted movement of MutSα. Therefore, these data confirmed that
MutSα moves by sliding along DNA but not bypassing the Lac repressor roadblock, which
validates the experimental system and its ability to test the prevailing models of human
MMR.
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Figure 3.4 Interaction between MutSα and mismatch-contained heteroduplex DNA in
the presence or absence of Lac repressor roadblocks.
EMSA was performed, incubating 300 bp 32P-labeled linear homoduplex substrate
containing a centrally located G-T mismatch as well as Lac repressor binding sites 5' and 3'
to the mismatch with MutSα (two blue-colored moon shapes facing each other) in the
presence or absence of Lac repressor (red oval) and ATP. Reaction products were analyzed
on a non-denaturing gel (see methods). Movement of MutS is restricted to the region
intervening between two Lac repressor-binding sites
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Lac repressor roadblocks significantly inhibit in vitro MMR.
EMSA data demonstrate that sliding of ATP-bound MutSα on the 300 bp DNA
susbsrate is limited to the region in between the two Lac repressor roadblocks. Therefore,
the assay system provides a way to test the hypothesis that MutSα slides from the mismatch
to the strand break, and that such sliding is an essential step in the MMR pathway (Gradia,
Acharya et al. 1997, Fishel 1998, Gradia, Subramanian et al. 1999, Jiang, Bai et al. 2005,
Mendillo, Mazur et al. 2005).
In order to evaluate the effect of Lac repressor roadblocks on MMR in vitro, a
heteroduplex DNA substrate containing a single G-T mismatch centrally-located and Lac
repressor-binding sites 5' and 3' to the mismatch was constructed (see section 2.11). The
DNA substrate also includes a DNA strand break 5' to the mismatch for strand
discrimination (Ghodgaonkar, Lazzaro et al. 2013) (Figure 2.3). The G-T mismatch lies
within overlapping recognition sites for restriction enzyme site, NsiI and XhoI. The DNA
substrate is insensitive to cleavage by NsiI, and the reaction product after correct repair of
the G-T mismatch to G-C is susceptible to NsiI digestion (Figure 2.1.A).
As shown in Figure 3.5, Lac repressor significantly inhibits in vitro MMR in the
presence of HeLa nuclear extract, which is consistent with the hypothesis. Moreover,
addition of IPTG, which dissociates Lac repressor from its binding site and removes the
roadblock, reduced but did not completely eliminate the Lac repressor-induced inhibition of
MMR (Figure 3.5-lane 3). Similar results were observed when the HeLa cell extract was
substituted with MSH-2 deficient NALM-6 (N6) nuclear extract (Matheson and Hall 2003),
or MLH1-deficient HCT116 (H6) nuclear extract, complemented with purified MutSα
(Figure 3.6.A-lane 1 and 2) or MutLα (Figure 3.6.B-lane 1 and 2), respectively (Figure
3.6.A/B-lane 4). Interestingly, MMR was not completely abolished by the Lac repressor
roadblocks (Figure 3.5-lane 2, Figure 3.6.A-lane 4, and Figure 3.6.B-lane 4), which
suggests that the system is slightly 'leaky', allowing some communication between the
mismatch and the nick. Although not shown here, increasing concentration of IPTG did not
fully alleviate Lac repressor-induced inhibition of MMR. Therefore, we conclude that
sliding of MutSα from the mismatch to a distal ssDNA break plays a role in MMR, but may
not be essential for MMR initiation, implying that MutSα may communicate with the strand
break in a manner that is independent of 2-dimensional sliding on the DNA.
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Figure 3.5 Lac repressor roadblock significantly inhibits in vitro MMR.
In vitro MMR assay was performed by incubating 30 fmol of 5’ G-T mismatch
heteroduplex substrate with 75 µg of HeLa nuclear extract in the presence or absence of Lac
repressor (as described previously in chapter 2.8.a). Products were visualized by using 1%
agarose gel with ethidium bromide staining. Addition of 4 fmol of Lac repressor (Lac I)
significantly inhibits MMR and displacement of Lac repressor by IPTG recovered the
inhibition of MMR, and displacement of Lac repressor by IPTG reduced the inhibition of
MMR. MMR (%) was quantified using Kodak Image Software.
A.

B.

Figure 3.6 Effect of Lac repressor roadblock on in vitro MMR in nuclear extracts
from MMR-defective cells complemented with purified protein.
(A) In vitro MMR assay in the presence of MSH2-defective N6 nuclear extract
complemented with purified MutSα protein in the presence or absence of Lac repressor. (B)
In vitro MMR assay in the presence of MLH1-deficient H6 nuclear extract complemented
with purified MutLα. MMR (%) was quantified using Kodak Image Software.
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Mismatch-provoked excision in the presence of Lac repressor roadblock.
The data presented above prompted us to hypothesize that MutSα sliding may not be
essential for initiation of DNA excision at the strand break. To investigate the molecular
details of the involvement of MutSα sliding in MMR initiation, in vitro DNA excision assay
was performed, followed by Southern blot analysis, postulating that the presence of
excision intermediates would provide evidence to support our hypothesis. In vitro excision
assay was carried out in the same manner as the MMR assay, except that dNTPs are omitted,
such that DNA resynthesis cannot occur. 5’ nick-directed heteroduplex DNA containing a
G-T mismatch and two Lac repressor-binding sites was incubated with HeLa or
MutSα-complemented N6 nuclear extract. 5’ nicked homoduplex DNA, otherwise identical
to the heteroduplex DNA substrate, was used as a negative control.
No excision intermediates were detected in reactions with homoduplex DNA, indicating
that DNA excision only initiates on heteroduplex DNA (i.e., only when a mismatch is
detected by MutSα). In the absence of Lac repressor, in vitro DNA excision proceeded
efficiently from the 5' strand break in mismatch-dependent manner in HeLa nuclear extracts
(Figure 3.7-lane 4). Similar results were observed in MutSα-complemented N6 nuclear
extract (Fig. 3.7-lane 7), but not when the extract was 'complemented' with heat-inactivated
WT MutSα (Fig. 3.7-lane 10).
As we confirmed in our EMSA (Figure 3.4-lane 5), placement of Lac repressor
roadblock leads to restriction of the sliding window of ATP-bound MutSα to the DNA
region intervening between two Lac repressor roadblocks. In addition, our previous in vitro
MMR assay demonstrated that Lac repressor roadblock significantly inhibits repair activity
(Figure 3.5-lane 2). Therefore, we assumed that mismatch-provoked excision would be
impeded in the presence of Lac repressor positioned between a mismatch and a strand break,
because prevention of MutSα sliding would supress communication between two distal
sites, which appears consistent with “sliding” model. Surprisingly, however,
mismatch-provoked excision proceeded efficiently from the strand break even in the
presence of Lac repressor roadblock (Figure 3.7-lane 5 and 8), suggesting that DNA
excision is independent of whether MutSα can or can not slide from the mismatch to the
5'-nick. However, DNA excision is also susceptible to inhibition by Lac repressor roadblock,
because the majority of DNA excision products ended at or closes to the edge of the Lac
repressor roadblock. Addition of IPTG, which allows displacement of Lac repressor,
reversed this inhibition (Figure 3.7-lane 6 and 9). These data show that mismatch-provoked
DNA excision begins at the strand break and terminates at the Lac repressor-binding site,
when the roadblock is present. These results imply that mismatch-bound MutSα can
communicate with (or interact with) the strand break even if it can not slide from the
mismatch to the strand break.
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In the Figure 3.7-lane 5 and 8, some excision intermediates terminate in between the two
Lac repressor roadblocks. These excision-termination products suggeset that DNA excision
initiates from more than one entry point, or that the amount of Lac repressor was not
sufficient to maintain full occupancy on all DNA substrate molecules in the reaction. In case
of the former, endogenous MutLα might have introduced addition nicks into the DNA
substrate. However, MutLα is not essential for 5’ nick-directed MMR on the present DNA
substrate, such that the majority of DNA excision must have started at the original 5' strand
break, not at MutLα-generated strand breaks. Thus, most of the excision products were
terminated at the first downstream roadblock as we found.
To test whether the amount of Lac repressor was insufficient, in vitro DNA excision
assay was carried out with increasing concentrations of Lac repressor, followed by southern
blotting analysis (Figure 3.8). In fact, the fraction of DNA excision intermediates
terminating at the first downstream roadblock increased with elevating amount of Lac
repressor (lane 6-8). However, Lac repressor could not be efficiently released by IPTG at
high concentration, so that high concentration of Lac repressor was not utilized in the in
vitro DNA excision assay. Moreover, 1.5 M concentration of Lac repressor was used to
rule out the possibility that high concentration of Lac repressor would form unnecessary
DNA looping (Rutkauskas, Zhan et al. 2009). Taken as a whole, these results suggest that
MutSα sliding is not essential to initiate MutSα-dependent signaling between the mismatch
and a strand break and that some other mechanisms may be involved in such
communication between two distal sites. Therefore, we conclude that MutSα can interact
with the strand break by sliding or by another as yet poorly defined mechanism, which
appears not reliable only on “sliding” model.
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Figure 3.7 Mismatch-provoked excision still proceeded from the 5’ nick regardless of
the presence of Lac repressor roadblock.
In vitro excision assay was performed basically in the same manner as in vitro mismatch
repair assay, except dNTPs were omitted to prevent DNA resynthesis (as described in
chapter 2.8). Either homoduplex or heteroduplex DNA was incubated with HeLa or MutSα
–complemented NALM-6 (N6) nuclear extract in the presence or absence of 1.5 M Lac
repressor. The excision products were digested with PstI and BglI, followed by southern
blotting analysis. The arrows indicate the position of the 5'- nick, the mismatch, and the
probe-binding site. Red circle and yellow bar show where Lac repressor (Lac I) binds and
where 32P-labled probe anneals, respectively.

47

Lane: 1

2

3

4

5

6

7

8

9

10

11

Figure 3.8 Increasing concentration of Lac repressors improves the roadblock effect
on excision termination at the first downstream roadblock.
In vitro excision assay was performed basically in the same manner as in vitro mismatch
repair assay, except dNTPs were omitted to prevent DNA resynthesis (as described in
chapter 2.8). Heteroduplex DNA was incubated with HeLa nuclear extract in the presence
or absnce of Lac repressors and IPTG. Different concentrations (0.5, 1.5, and 3.0 M) of
Lac repressors were used to see the effect of Lac repressor concentration on termination of
excision at the first downstream roadblock site. The excision products were scored by PstI
and BglI and then followed by southern blotting analysis. The arrows indicate the position
of the 5'- nick, the mismatch, and the probe-binding site. Red circle and yellow bar show
where Lac repressor (Lac I) binds and where 32P-labled probe anneals, respectively. (Lane
1: first downstream Lac I binding site close to a nick, lane 2: full size of the non-excised
fragment, lane 3: another Lac I binding site, lane 4: mismatch)
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DISCUSSION
Our study investigated the molecular mechanism by which mismatch-bound MutSα
transmits a signal from the mismatch to a distal strand break during MMR. Several models
explaining the mechanism of MMR initiation have been developed and proposed (Figure
1.6), including “stationary” model (Junop, Obmolova et al. 2001, Guarne, Ramon-Maiques
et al. 2004), “translocation” model (Allen, Makhov et al. 1997, Blackwell, Bjornson et al.
1998, Blackwell, Martik et al. 1998), and “sliding” model (Gradia, Acharya et al. 1997,
Fishel 1998, Gradia, Subramanian et al. 1999, Jiang, Bai et al. 2005, Mendillo, Mazur et al.
2005). In this study, we demonstrated that mismatch-provoked excision is independent of
whether sliding of MutS is restricted by Lac repressor roadblock, which appears to dispute
the validity of MMR models that invoke “sliding” by MutSα as a critical step.
A strand break is indispensable for discriminating the newly 'nascent' daughter DNA
strand from the parental strand in human MMR. However, the strand break can be several
hundred bp away from the mismatch, raising the question of how two physically distant
sites communicate each other during MMR. To explore the mechanism that mediates the
communication, Lac repressor/Lac operator system was used as a physical “roadblock”
intervening between the mismatch and the nick and applied to in vitro excision or MMR
system to prevent MutS sliding.
EMSA results shown in Figure 3.4 confirm that MutS diffuses away from a mismatch
in ATP-dependent manner. This result is consistent with previous studies showing that the
exchange of ADP for ATP triggers conformational change in MutS (Blackwell, Bjornson
et al. 1998, Blackwell, Martik et al. 1998, Bjornson, Allen et al. 2000) and reduces the
affinity of MutS for the mismatch. ATP-binding also promotes opening of the DNA clamp,
allowing DNA sliding to initiate (Gradia, Acharya et al. 1997, Gradia, Subramanian et al.
1999, Wilson, Guerrette et al. 1999, Acharya, Foster et al. 2003, Mendillo, Mazur et al.
2005). The observation that MutSα sliding was restricted to the DNA region between two
Lac repressor roadblocks (Figure 3.4) indicates that the movement of MutSα induced by the
presence of ATP is indeed mediated by “sliding”, not by “hopping”. If ATP-bound MutSα
utilizes “hopping” to move along the DNA, it would bypass the roadblock and most likely
fall off the DNA. However, in the presence of Lac repressor roadblock, MutSα remained
bound to the DNA substrate even in the presence of ATP, indicating that the physical
roadblock limits MutSα sliding to an internal segment of the linear DNA substrate.
Restriction of MutSα sliding significantly inhibits in vitro MMR (Figure 3.5 and 3.6),
and IPTG reduces the inhibition, suggesting that MutSα sliding plays a role in signaling
MMR initiation. However, IPTG did not fully reverse Lac repressor-induced inhibition of
MMR, suggesting that IPTG fails to completely remove Lac repressors roadblocks.
Furthermore, MMR was not fully abolished in the presence of Lac repressor, implying that
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sliding of MutSα is not absolutely required to initiate MMR. This could mean that MutSα
can communicate with a distal ssDNA break by a mechanism that does not involve sliding.
More importantly, in vitro excision assays surprisingly revealed that
mismatch-provoked DNA excision initiates from the strand break even in the presence of
Lac repressor roadblock (Figure 3.7), which prevents MutSα from sliding from the
mismatch to the nick. The observation that DNA excision was terminated at the first
downstream roadblock site suggests that MutSα may translocate and then transmit
MMR-start signal to the strand break during the early steps of MMR. However, previous
theoretical studies suggest that ATP-induced sliding of MutSα away from the mismatch is
essential during overall MMR process, because it promotes accessibility for Exo1-catalyzed
excision (Jeong, Cho et al. 2011, Cho, Jeong et al. 2012, Qiu, DeRocco et al. 2012). Taken
together, these results question the validity of MMR models that invoke “sliding” of MutS
between the mismatch and the nick, lending support to models that invoke translocation or
other mechanisms of communication between two distant DNA sites during MMR in
human cells. This study therefore provides significant insight into the mechanism of
initiation of human MMR.

Copyright © Sanghee Lee 2014
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CHAPTER FOUR
MOLECULAR REGULATION OF MUTSα ATPASE AND ITS INVOLVEMENT
IN MMR INITIATION

INTRODUCTION
The MutSα, which is composed of MSH2 and MSH6 subunits, exists as a heterodimer
and recognizes a mismatch. In addition to mismatch recognition, MutSα possesses an
intrinsic ATPase, which is critical to its cellular roles in MMR. Thus, mutations in the
ATPase domain of MSH2 or MSH6 subunit of the MutSα heterodimer impair MMR
(Iaccarino, Marra et al. 1998, Dufner, Marra et al. 2000). Like many other members of the
ATP binding cassette (ABC) protein superfamily, both MSH2 and MSH6 have ATPase
domains that contain highly conserved Walker A and Walker B motifs (Hopfner and Tainer
2003). The Walker A motif consensus amino acid sequence is GXXXXGKS/T, where X is
variable as any amino acid, and S/T indicates serine (S) or threonine (T); this motif is
believed to include amino acids that form the nucleotide binding pocket. The Walker B
motif consensus amino acid sequence is DD/EXX, where D/E indicates either aspartic acid
(D) or glutamic acid (E); this motif is assumed to require for ATP hydrolysis
(Ramakrishnan, Dani et al. 2002). The Walker A motif corresponds to residues 669–676
and the Walker B motif corresponds to residues 748–751 in MSH2, while the Walker A
motif corresponds to residues 1134–1141 and the Walker B motif corresponds to residues
1213-1216 in MSH6.
MSH2 and MSH6 have different affinities for nucleotide cofactors; for example, MSH6
binds ATP with higher affinity than MSH2, and stable binding of ATP to MSH6 decreases
the affinity of MSH2 for ADP (Antony and Hingorani 2003, Martik, Baitinger et al. 2004).
The ATPase domain of MutSα is the most highly conserved region of the protein (Warren,
Pohlhaus et al. 2007), and it is also involved in MutSα dimerization (Figure 1.4). Mismatch
binding by MutSα triggers downstream MMR events, including interaction with other
MMR proteins, and DNA sliding (Drummond, Li et al. 1995, Alani, Sokolsky et al. 1997,
Gradia, Subramanian et al. 1999). When mismatch-bound MutSα binds ATP, it undergoes a
conformational change and forms a sliding clamp (Figure 1.5), which has the ability to
dissociate from the mismatch due to reduced mismatch binding affinity (Gradia, Acharya et
al. 1997, Gradia, Subramanian et al. 1999, Wilson, Guerrette et al. 1999, Acharya, Foster et
al. 2003, Mendillo, Mazur et al. 2005). Although some biochemical functions of MutS are
relatively well known, the role of MutSα ATPase activity during the initiation step(s) of
MMR is not understood in any detail. Additionally, how the Walker motifs of both MSH2
and MSH6 subunits contribute to the MutSα functions is not fully understood.
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To address this issue, a series of ATPase-deficient MutSα mutants were generated
through site-directed mutagenesis of the cloned MSH2 and MSH6 genes, and the mutant
proteins were purified and characterized. More specifically, alanine substitution mutations
were generated at K675 and G673 (K1140A and G1138A in MSH6) in the Walker A motif,
and a lysine substitution mutation was introduced at E749 in the Walker B motif of MSH2
(E1140K in MSH6). Heterodimers carrying one or both mutant subunits were prepared in
insect cells and extensive characterization of the mutant proteins including ATP binding,
ATP hydrolysis, MMR, excision, and ATP-dependent DNA sliding was performed. In this
study, it was shown that diffusion of MutS along DNA requires ATP binding and Mg2+ but
does not require ATP hydrolysis, which is consistent with previous findings that ATPγS
(nonhydrolyzable ATP) induced release of MutSα from the mismatch (Allen, Makhov et al.
1997, Blackwell, Martik et al. 1998, Iaccarino, Marra et al. 2000, Blackwell, Bjornson et al.
2001, Jiang, Bai et al. 2005). It is worth mentioning that the ATP binding-induced MutS
sliding is dependent on the presence of magnesium, so that the absence of magnesium leads
to direct dissociation of MutS from the mismatch (Iaccarino, Marra et al. 2000, Lebbink,
Fish et al. 2010). Interestingly, we found that E-K substitutions in the Walker B motif
produce a mutant MutSα that, instead of sliding off, undergoes direct dissociation from a
mismatch-containing DNA molecule regardless of the presence of magnesium. This result
suggests that E749 (E1140) in the Walker B motif of MSH2 (MSH6) plays a role in binding
Mg2+ and is indispensable for MutSα conformational change to form a sliding clamp.
Furthermore, we demonstrated that ATPase-defective MutS carrying K675A in MSH2,
K1140A MSH6 or both were deficient in ATP-induced sliding but promoted initiation of
DNA excision at a nick. Therefore, this study supports the hypotheses 1) that DNA strand
discrimination by MutS bound to a mismatch does not require MutS sliding away from
the mismatch, and 2) that MutS promotes communication between the mismatch and the
nick in an ATP hydrolysis-independent and DNA sliding-independent manner, which
implies that MuS might be able to physically interact with the strand break. Based on these
results, a model is proposed to explain how MutS transmits signals that initiate MMR in
human cells carrying DNA mismatches in newly-syntehesized DNA strand.
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RESULTS
Characterization of MutSα with mutations in Walker A and Walker B motifs of
MSH2 and/or MSH6.
The following experiments test whether it is obligatory that MutS slide away from the
mismatch during initiation of MMR. To identify the effect of ATPase-deficient MutS
mutants on in vitro MMR initiation, in vitro MMR or excision assay was performed using
ATPase-defective mutants of MutS. The QuikChange site-directed mutagenesis method
(described in Chapter 2.15) was used to generate MSH2 K675A (or MSH6 K1140A) and
MSH2 E749K (or MSH6 E1214K), mutations in Walker A and B motifs of hMSH2 (or
hMSH6). The postion of the mutations are shown in Figure 4.1.A in which Walker A
mutants were colored red while Walker B mutants were colored blue (Protocols for
mutagenesis and purification of mutant proteins are described in detail in Chapter 2.).
Mutations were generated in either MSH2 or MSH6 or both subunits, because previous
studies suggest asymmetry in how the MutS heterodimer binds mismatches or hydrolyzes
ATP (Drotschmann, Yang et al. 2001, Antony, Khubchandani et al. 2006, Warren, Pohlhaus
et al. 2007). For completeness, studies were performed with MSH2-defective heterodimer,
MSH6-defective heterodimer and double-mutant heterodimer. Wild type heterodimer was
used as a positive control. MutSα wild type or mutants were expressed in insect cells using
the Bac-to-Bac expression system and purified through His-tag Nickel column, Mono Q
column, and SuperdexTM 200 Gel Filtration (Figure 4.1.B; Chapter 2.13). To evaluate how
ATPase deficiency of MutSα contributes to in vitro MMR, in vitro MMR assay (Chapter
2.8) were performed using MSH2-deficient NALM-6 (N6) nuclear extract complemented
with wild type or mutant purified MutSα (Gu, Cline-Brown et al. 2002, Zhang, Yuan et al.
2005). Figure 4.1.C demonstrated that purified wild type MutSα is MMR-proficient, while
the purified mutant MutSα is not, suggesting that ATPase activity of MutSα is essential for
in vitro MMR (Note that the N6 nuclear extract is MMR-deficient in the absence of
exogenous wild type MutSα.).
To address the individual contribution of MSH2 and/or MSH6 mutants to ATP
processing, we examined magnesium-dependent ATP binding and hydrolysis, following
previous description (Chapter 2.3 & 2.10). As previous studies have demonstrated that
MSH6 subunit displays higher affinity to ATP than MSH2 subunit in the absence of
magnesium (Mazur, Mendillo et al. 2006), a similar result was obtained here (Figure 4.2.A).
However, all MutS mutants except 2WT/6E1214K are cross-linked to ATP with very low
efficiency (relative to wild type), suggesting that MSH2 K675 and E749 in Walker A and
Walker B motif, respectively play a role in ATP binding. Alanine or lysine substitution
mutations at MSH6 K1140 and E1214 (i.e., 2WT/6K1140A and 2WT/6E1214K did not
appear to strongly decrease the affinity of wild type MSH2 for ATP in the presence of
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magnesium, while all proteins carrying mutations of MSH2 K675A or E749K (i.e.,
2KA/6WT, 2KA/6KA, 2EK/6WT, and 2EK/6EK) were completely deficient in
ATP-binding. These results suggest that MSH2 plays a greater role in regulation of ATP
binding by MutS than MSH6.
The ATP hydrolysis activity of mutant MutS proteins was examined by incubating
mutant and wild type MutS with [γ-32P]-ATP; reaction products were analyzed by
electrophoresis on a 20% denaturing polyacrylamide gel. This experiment showed a strong
defect in ATPase for all MutS mutant proteins carrying MSH2 K675A or E749K (i.e.,
2KA/6WT, 2KA/6KA, 2EK/6WT, and 2EK/6EK) (Figure 4.2.B). However, a weaker but
major defect in ATPase was observed in MSH6 K1140A and MSH6 E1214K (i.e.,
2WT/6KA or 2WT/6EK), which was not found in MSH2 K675A and MSH2 E749K,
suggesting that MSH2 plays a greater role than MSH6 during ATP binding by MutS. Thus,
as mentioned above, MSH2 and MSH6 appear to contribute asymmetrically to ATP
hydrolysis by MutS, which is consistent with the results of earlier studies. This
characteristic of MutS may partially explain the fact that mutations in MSH2 are linked to
HNPCC more frequently than mutations in MSH6.
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A.
Walker A domain: GXXXGKS/T
MutS GPNMGGKSTYMRQT
yMsh2 GPNMGGKSTYIRQV
yMsh6 GANAAGKSTILRMA
hMSH2 GPNMGGKSTYIRQT
hMSH6 GPNMGGKSTLMRQA

B.

Walker B domain: D(D/E)XX
MutS SLVLMDEIGRGTST
yMsh2 SLIIVDELGRGTST
yMsh6 SLLVVDELGRGGSS
hMSH2 SLIIIDELGRGTST
hMSH6 SLVLVDELGRGTAT

C.

Figure 4.1 Purification and in vitro MMR assay of ATPase-defective MutSα mutants.
(A) Conserved amino acid sequence alignment of Walker A and Walker B motifs in MutSα
homologues. Position of MSH2 K675A (red) and MSH2 E749K (blue) mutations are
indicated. (B) Purified wild-type (WT) and ATPase-deficient MutSα analyzed by 10%
SDS-PAGE (Chapter 2.13). (C) In vitro MMR assays were performed using 80 μg of
MSH2-defective N6 nuclear extract and purified wild type or mutant MutSα, as indicated.
None of ATPase-deficient MutSα mutants have MMR activity, suggesting that ATPase
activity of MutSα is required for proficient MMR in vitro.
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A.

B.

Figure 4.2 ATP binding and ATPase activities of MutSα wild type and
ATPase-deficient mutants.
(A) Wild type or mutant MutSα (1 µg) was incubated with 3000 Ci/mmol of [γ-32P]-ATP (X
µM) in the presence of G/T mismatch-containing dsDNA (100 ng) and 2 mM MgCl2.
Reactions were subjected to UV cross-linking and analyzed by SDS-PAGE (described in
Chapter 2.10). Dried gels were analyzed with Typhoon PhosphorImager. (B) ATPase assay
was performed under the same conditions as ATP binding (described in Chapter 2.3), except
that reactions were incubated at 37°C for 20 min, and analyzed by 20% denaturing PAGE.
The 32P-labeled species were detected and quantified by using a Typhoon PhosphorImager.
The bottom band indicates a phosphate derived from [γ-32P]-ATP hydrolyzed by ATPase of
MutSα.
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The mismatch binding activity of MutS mutants was examined using EMSA assay, in
which proteins were co-incubated with a 100 bp 32P-labeled DNA substrate containing a
G-T mismatch in the presence or absence of ATP, followed by electrophoresis under
non-denaturing conditions. The results demonstrate that Walker A mutants and Walker B
mutants play distinct role in mismatch binding and dissociation. All MutS mutants, except
MutS with SH2 K675A/MSH6 K1140A (i.e., double Walker A motif mutant) form
stable complexes with the mismatch-containing substrate (Figure 4.3.A), suggesting some
communication between the mismatch binding domain and the ATPase domain of MutS
even though crystal structure models show that the two domains are physically far from
each other (Warren, Pohlhaus et al. 2007). However, the mechanistic basis for
communication between these domains remains unanswered. Since the ATP-binding sites
can be occupied by different ligands, these two distant domains exist in several different
combinations, which results in that ATP-binding might alter the conformation of one or
both domains (Gradia, Acharya et al. 2000, Warren, Pohlhaus et al. 2007). Thus, it has been
difficult to exclusively determine ATP-binding states of MutS in different stages of MMR
events. However, distinct ATP-binding states of MutS conformations or modes of ATP
binding have not yet been correlated with different stages of MMR. Additional studies of
MutS mutants, including the Walker A motif mutant discussed above, might shed insight
on these questions.
Previous studies have demonstrated that binding of ATP to MutS is sufficient to allow
MutS to slide away from the mismatch, while the process does not require ATP-hydrolysis
(Allen, Makhov et al. 1997, Blackwell, Martik et al. 1998, Iaccarino, Marra et al. 2000,
Blackwell, Bjornson et al. 2001, Jiang, Bai et al. 2005). However, ATP binding fails to
dissociate the Walker A mutants of MutS from the mismatch, and a strong asymmetry in
the impact of Walker A and Walker B mutants was observed (Figure 4.3.A). In particular,
addition of ATP did not promote dissociation of MSH2 K675A/MSH6 WT or MSH2
WT/MSH6 K1140A (Figure 4.3.A-lane 11 & 13), while Walker B mutants and MutS WT
dissociated from the mismatch in the presence of ATP (lane 3, 5 & 7). This suggests that
residues in the MutS Walker A motif, including K675 in MSH2 (K1140 in MSH6), play
an essential role in ATP-dependent MutS sliding per se, and/or in release/dissociation of
MutS from a mismatch. Therefore, we conclude that the Walker A motif of MutS, plays
a role in ATP binding by MutS, while the Walker B motif may be dispensible for ATP
binding. It is worth noting that Walker A double mutant MSH2 K675A/MSH6 K1140A is
deficient in both ATP binding and ATP hydrolysis (shown in Figure 4.2), but this mutant
retains mismatch-specific binding as well as ATP-dependent dissociation from the
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mismatch. This result suggests that mutation in both MSH2 and MSH6 subunit might
induce some conformationtal change of MutS, so that ATP alters the interaction of the
2KA/6KA double mutant with the mismatch even though the protein is defective in ATP
binding; thus, by some unknown mechanism, ATP results in dissociation of MSH2
K675A/MSH6 K1140A from the mismatch.
Walker B mutants of MutS (i.e., variants carrying MSH2 E749K, MSH6 E1214K or
both) responded in the same manner as mismatch-bound WT MutS to the presence of
ATP; namely, ATP-induced dissociation of MutS from the mismatch (Figure 4.3.A). The
ATP binding-induced sliding also requires magnesium, while chelation of (or absence of)
magnesium causes ATP-induced direct dissociation of MutS (Iaccarino, Marra et al. 2000,
Lebbink, Fish et al. 2010). To test whether E749 in MSH2 and E1214 in MSH6 (within the
Walker B motif) play a role in this process, Walker B mutants of MutS were incubated
with a 300 bp GT mismatch-containing 32P-labeled dsDNA fragment carrying Lac
operator/repressor 'roadblocks' flanking the mismatch (see Chapter 3 for details about DNA
substrates with Lac operator/repressor 'roadblocks'). The reaction products were analyzed
by EMSA, and it appeared that E-K substitutions in the Walker B motif produce a mutant
MutSα that, instead of sliding off, undergoes direct dissociation from a
mismatch-containing DNA molecule regardless of the presence of magnesium (Figure
4.3.B). This suggests that the glutamate (E) residue in the Walker B motif of MSH2 or
MSH6 may be required for magnesium binding. Therefore, it seems logical that the Walker
B motif should also be indispensable for ATP-induced distinct conformational change of
MutSα to form a sliding clamp, specifically in terms of magnesium binding during ATP
binding.
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Figure 4.3 Effects of ATPase-defective MutSα mutants on mismatch binding and ATP
binding-induced mismatch release.
(A) EMSA with WT and ATPase defective MutSα was carried out as previously described
(Chapter 2.6) in the presence or absence of 2 mM ATP, using a 100 bp of 32P-labeled DNA
substrate (end-free) containing a G-T mismatch. (B) EMSA analysis as in (A), except 300
bp of 32P-labeled DNA substrate carrying Lac operator/repressor "roadblocks" between the
mismatch and the DNA termini, was carried out in the presence or absence of magnesium.
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Initiation of Mismatch-provoked excision in vitro is independent of MutSα sliding,
but dependent of MutSα remained bound at the mismatch.
In support of previous studies demonstrating that ATPase activity of MutSα is obviously
essential for its function in MMR, all the ATPase-deficient MutSα mutants generated in this
study failed to complete in vitro MMR (Figure 4.1.C). However, the role of
MutSα-catalyzed ATP hydrolysis during the DNA excision step of MMR has not been
resolved in studies reported to date. Based on the results of in vitro DNA excision assays
described in Chapter 3, DNA excision can initiate at a nick, even when sliding of MutSα
from the mismatch to the nick is blocked. To explore this further, an in vitro excision assay
was carried out, using MutSα 2KA/6WT and 2WT/6KA proteins that are proficient in
mismatch binding but deficient in ATP-dependent dissociation/sliding from the mismatch.
Reaction products were analyzed by Southern blot (Figure 4.4.A). The results demonstrate
normal Exo1-catalyzed DNA excision in reactions with MutSα 2KA/6WT or 2WT/6KA,
confirming that DNA excision starts in the absence of MutSα sliding. Remarkably, the
majority of DNA excision intermediates terminate at the mismatch, and few if any DNA
excision intermediates terminate beyond the mismatch in the presence of MutSα 2KA/6WT
or 2WT/6KA. In contrast, DNA excision intermediates had a strikingly different, showing
nearly random length distribution in the presence of wild type MutSα. These findings
suggest that excision initiated from the nick terminates when it encounters MutSα
2KA/6WT or 2WT/6KA stably bound at the mismatch due to defective ATP binding and
defective ATP-dependent sliding. It is noted that the frequency of termination at the
mismatch is higher in the presence of MutSα 2KA/6WT than in the presence of 2WT/6KA;
this is consistent with the observation that MutSα 2KA/6WT binds ATP less efficiently than
MutSα 2WT/6KA.
Previous studies demonstrated that the absence of magnesium induces direct
dissociation of MutSα from the mismatch in the presence of ATP (Iaccarino, Marra et al.
2000, Lebbink, Fish et al. 2010). However, MutSα Walker B mutants exhibit direct
dissociation from the mismatch, instead of sliding off, in an ATP-dependent
magnesium-independent manner (Figure 4.3.B-lane 9), suggesting that the Walker B motif
plays a role in magnesium binding, possibly by regulating conformational change of MutSα.
To explore this further on initiation of excision, DNA excision intermediates generated in
the presence of MutSα 2EK/6WT or 2WT/6EK were analyzed by Southern blot (Figure
4.4.A). Notably, MutSα 2EK/6WT and 2WT/6EK, which bind mismatches but do so in a
transient or relatively unstable manner did not support initiation of Exo1-catalyzed excision,
implying defective initiation of MMR in the absence of ATP binding-mediated
conformational change of MutSα. One interpretation of this result is that sliding of MutSα
requires a conformational change induced by binding of magnesium and ATP; hence,
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Walker B mutants, which fail to undergo this conformational change because of the
deficiency in ATP binding, do not support initiation of MMR. Therefore, we conclude that
stable binding of MutSα to the mismatch, rather than sliding, is critical for initiation of
MMR. However, once Exo1-catalyzed DNA excision initiates, MutS must dissociate
from the mismatch to allow the repair reaction to proceed beyond the mismatch. If MutSα
fails to dissociate from the mismatch, Exo1-catalyzed DNA excision is blocked, the
misinserted nucleotide is not removed, and the repair reaction aborts.
To confirm this above hypothesis, DNA excision reactions were terminated 3, 6 or 12
minutes after initiation in the reconstituted system using purified MutL, RPA, and wild
type or mutant MutSα. As a positive control, excision assay was performed in the presence
of MMR-proficient HeLa cell nuclear extract and terminated 2, 5, 10 min after initiation.
The DNA probe hybridized close to the PstI site in the DNA substrate. In the presence of
HeLa nuclear extract, DNA excision intermediates were distributed nearly randomly from
the nick to close to the PstI site (Figure 4.4.B). In the DNA excision reaction with wild type
MutSα, excision intermediates at the mismatch site gradually disappear over time,
suggesting that wild type MutSα slides away from the mismatch after (but not before) DNA
excision initiates. Therefore, DNA excision correlates with but precedes initiation of MutSα
sliding. Remarkably, MutSα 2KA/6WT or 2WT/6KA, which is capable of mismatch
binding but incapable of ATP-induced mismatch release, terminated Exo1-catalyzed
excision at the mismatch, demonstrating that DNA excision starts independently of whether
MutSα slides away from the mismatch. In contrast, DNA excision was not observed at any
time point in the presence of MutSα 2WT/6EK, indicating that Walker B MutSα mutants,
which exhibit ATP-induced direct dissociation from the mismatch, cannot initiate excision.
This result implies that stable binding of MutSα to the mismatch is essential to support
initiation of excision.

61

A.

1

2

3

4

5

6

7

8

9

10 Lane

B.

1

2

3 4 5 6

62

7 8 9 10 11 12 13 Lane

Figure 4.4 Requirement for stable binding of MutSα to the mismatch during initiation
of MMR.
(A) In vitro excision assay was performed as described in Chapter 2.8 in the presence of
MutSα Walker A and Walker B mutants. 5’ nick-directed G-T mismatch heteroduplex DNA
was used in either HeLa nuclear extract system or reconstituted system using purified MMR
proteins including MuLα, Exo1, and RPA. DNA excision products were digested with PstI
and BglI and subjected to Southern blot analysis. Arrows indicate the positions of the nick
and the mismatch; the yellow bar indicates the 32P-labeled probe-annealing site. (B) Assays
were carried out as in (A), except reactions were terminated at the indicated time.

MutSα-mediated signaling during initiation of MMR in vitro.
Data presented above demonstrated that DNA excision initiates at an upstream nick in
the presence of mismatch-bound MutSα 2KA/6WT or 2WT/6KA, despite the fact that this
mutants are defective in ATP binding-dependent sliding. Although this suggests that sliding
of MutS is not essential for initiation of MMR, an alternative explanation is that MutSα
2KA/6WT and MutSα 2WT/6KA may have sufficient residual ATP binding and thereby
ATP-induced sliding activity to support this reaction. To rule out the latter possibility,
MutSα mutants carrying MSH2 G673A and/or MSH6 G1138A were generated and
characterized (Figure 4.5). Note that MutS mutants carrying MSH2 G673A and/or MSH6
G1138A in the Walker A motif, which are proficient in mismatch binding capacity, are
completely deficient in ATP hydrolysis (Figure 4.5.C), deficient in ATP binding-dependent
mismatch release (Figure 4.5.D) and do not support in vitro MMR (Figure 4.5.E). Southern
blot analysis of in vitro excision products showed that DNA excision initiates at the nick in
the presence of MutSα 2WT/6GA and 2GA/6GA and mostly terminates at the mismatch
(Figure 4.6). This result implies that MuS 2WT/6GA or 2GA/6WT remain bound at the
mismatch even after Exo1-catalyzed DNA excision initiates, suggesting that
mismatch-bound MutS probably physically interacts with the strand break to transmit an
entry signal of MMR. When the DNA substrate also carried Lac repressor/operator
roadblocks, the experiment result was the same. Therefore, we conclude that ATP
hydrolysis and sliding of MutSα to the nick is dispensable for signal transmission of in vitro
MMR initiation. However, interestingly 2GA/6WT exhibits like wild type of MutS in
terms of ATP binding-dependent dissociation form the mismatch (figure 4.5.D), suggesting
MSH6 subunit contributes more to MutS-induced ATP processing than MSH2 (Iaccarino,
Marra et al. 1998, Antony, Khubchandani et al. 2006). In addition, Exo1-catalyzed excision
was also initiated and extended by 2GA/6WT, not showing termination of excision
intermediates at the mismatch (figure 4.6), which indicatse that 2GA/6WT stimulated
initiation and extension of excision farther beyond the mismatch. Since ATP induces
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dissociation of 2GA/6WT from the mismatch, Exo1-catalyzed excision is not terminated at
the mismatch. This suggestion appears linked to the fact that only MSH6, but not MSH2,
has a conserved Phe-X-Glu motif that recognizes and directly binds to a mismatch (Lamers,
Perrakis et al. 2000, Obmolova, Ban et al. 2000, Warren, Pohlhaus et al. 2007, Edelbrock,
Kaliyaperumal et al. 2013). It is worth mentioning that although ATPase domain and
mismatch binding domain of MSH6 are located far from each other, there is allostery
between them (Warren, Pohlhaus et al. 2007). However, how mismatch binding domain of
MSH6 coordinates with its ATPase domain for its conformational change signal is not clear.
Our finding possibly is reflected in this question, demonstrating that ATP binding to MSH6
facillitates formation of appropriate sliding clamp in order to cause ATP-induced mismatch
release, and leading to a reduction in mismatch binding of ATP-bound MutS. Therefore,
these studies improve our understanding of MutS-mediated signaling during MMR and
call into question the validity of the 'sliding model' for eukaryotic MMR.
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A.

B.
Walker A domain: GXXXGKS/T
MutS GPNMGGKSTYMRQT
yMsh2 GPNMGGKSTYIRQV
yMsh6 GANAAGKSTILRMA
hMSH2 GPNMGGKSTYIRQT
hMSH6 GPNMGGKSTLMRQA

C.

D.

Figure 4.5 Biochemical characteristics ATPase-deficient MutSα with G-A substitution
mutations in the Walker A motif.
(A) Conserved amino acid sequence of Walker A domain of MutSα homologues; MSH2
G673 and/or MSH6 G1138 (shown in red) were substituted with alanine. (B) 10%
SDS-PAGE of wild type (WT) and MutSα with MSH2 G673A and/or MSH6 G1138A. (C)
ATPase assay in the presence of 50 nM proteins, [γ-32P]-ATP, 5 mM MgCl2 in the presence
or absence of 100 bp of 32P-labeled DNA (Chapter 2.3). The 32P-labeled species were
quantified by PhosphorImager. (D) EMSA in the presence or absence of 2 mM ATP, using
100 bp 32P-labeled DNA heteroduplex. (E) In vitro MMR assays were performed as
described in Chapter 2.8 using 80 μg N6 nuclear extract complimented with wild type or
mutant MutSα.
65

Figure 4.6 Exo1-catalyzed excision occurs efficiently from the nick independently of
whether MutSα slides from the mismatch to the nick.
In vitro DNA excision assay was performed using 5' nicked heteroduplex DNA including
Lac repressor/operator roadblocks in the presence of HeLa nuclear extract or reconstituted
MutSα system using purified MMR proteins including MuLα, Exo1, and RPA. The excision
products were analyzed by southern blotting, using 6% denaturing gel as described
previousy. The arrows indicate the nick and the mismatch site. Red circle and solid bar
show Lac repressor binding site and 32P-labeled probe annealing site.

66

Figure 4.7 Requirement for mismatch-bound MutSα during initation of MMR.
In vitro DNA excision assay was performed as described in Chapter 2.8, in the presence of
wild type or mutant MutSα, and 5' nicked heteroduplex DNA. HeLa nuclear extract or
purified MMR proteins were added, as indicated. Reactions were terminated at the indicated
time. DNA excision products were analyzed as described above. Arrows indicate the
positions of the nick and the mismatch; the yellow bar indicates the probe-annealing site.
MutSα 2GA6GA mutant markedly promotes termination products of excision observed at
the mismatch area as increasing the reaction time. It suggests that excision starts
independently of whether MutSα slides from the mismatch to the strand break. The Walker
B mutant MutSα, which is incapable of staying at the mismatch, did not initiate excision,
indicating that MutSα remaining bound at the mismatch, rather than sliding, is essential for
the initiation of excision.
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DISCUSSION
Although a human homolog of MutH has not been identified (Kunkel and Erie 2005),
human MMR process involves a strand specific nick, which is generated by discontinuities
between Okazaki fragments on the lagging strand or the 3’ terminus of replication fork on
the leading strand (Lopez de Saro and O'Donnell 2001). However, in spite of extensive
studies, how MutS facilitates communication between the mismatch to the distal strand
discrimination signal (the nick) to initiate MMR remains controversial. As described in the
introduction, three models have been proposed to explain initiation of MMR in human cells.
Major differences among these models include how MutS translocates to the strand break
and whether ATP hydrolysis of MutS is required. In this study, we ruled out the
“translocation” model (Figure 1.6 left) among these models, because MutS slides from the
mismatch to the strand break in ATP-binding dependent manner, not in ATPase dependent
manner (Figure 4.3), and ATP hydrolysis is not required for the initiation of MMR. To
clarify the mechanism of MMR initiation, molecular details of excision reactions containing
MutS mutants that are defective in ATP-binding depedent sliding were observed.
Although all ATPase-deficient MutS mutants did not exhibit in vitro MMR (Figure 4.1.C
and 4.5.E), MutSα Walker A mutants, which are capable of mismatch binding but incapable
of ATP-mediated sliding, appears to start Exo1-catalyzed excision (Figure 4.4 and 4.6). It
suggests that MutS sliding from the mismatch to the nick is not essential for
communication between two distal sites. Moreover, majority of excision intermediates
provoked by MutSα Walker A mutants was terminated at the mismath site, indicating that
they remained bound at the mismatch even after Exo1-catalyzed DNA excision initiated.
This observation suggests that MutSα stayed bound at the mismatch is sufficient to transmit
a MMR start signal to the strand break and then initiate MMR. In contrast, excision was not
provoked by MutSα Walker B mutants (Figure 4.4), whose mismatch binding is in a
transient or unstable manner, implying that stable mismatch binding of MutSα, rather than
sliding, is necessary to support initiation of excision. However, once Exo1-catalyzed DNA
excision initiates, MutS must dissociate from the mismatch to allow the repair reaction to
proceed beyond the mismatch. If MutSα fails to dissociate from the mismatch,
Exo1-catalyzed DNA excision is blocked, the misinserted nucleotide is not removed, and
the repair reaction aborts. In addition, as the reaction time increases, excision proceed
efficiently from the nick beyond the mismatch by wild type of MutS, while majority of
excision reactions was terminated at the mismatch by MutS mutants, which are defective
in ATP-induced mismatch release. This result provides strong evidence to support the
hypothesis that sliding of MutS away from the mismatch is absolutely not required for
translocation of MutS to the nick to initiate MMR, suggesting that MutSα can
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communicate with a distal ssDNA break by a mechanism that does not involve sliding.
Mismatch-bound MuS probably physically interact with the strand break in order to
transmit an MMR start signal and then initiate MMR.
Although initiation of Exo1-provoked excision supported by MutS mutants showed
that sliding of MutS away from the mismatch is not essential for the initiation of MMR,
there is another possibility that the MutS mutants may still have sufficient capacity of
ATP-induced mismatch release to start MMR. To rule out the possibility, excision reactions
including the MutS mutants were carried out in the presence of Lac repressor roadblocks
to additionally (note that mutants themselves are deficient in ATP-induced sliding from the
mismatch) restrict the sliding window of ATP-bound MutSα to the DNA region intervening
between two Lac repressor roadblocks. Exo1-catalyzed excision provoked by either MutS
2WT/6GA or 2GA/6GA mutants proceeds efficiently from the strand break even in the
presence of Lac repressor roadblock (Figure 3.7-lane 5 and 8), suggesting that DNA
excision is indeed independent of whether MutSα can or cannot slide from the mismatch to
the 5'-nick.
In contrast of the sliding model, our finding is more likely close to stationary model at
the beginning of MMR events, in which sliding of MutS is not required. However, once
Exo1-catalyzed DNA excision initiates, MutS must be released from the mismatch to
allow the repair reaction to proceed beyond the mismatch. Thus, sliding of MutS away
from the mismatch is definitely essential for later process of MMR after Exo1 encounters
the mismatch. In conclusion, as shown in the Figure 4.9, our proposed model is kind of
mixed both stationary and sliding models. MutS recognizes and binds a mismatch in
ADP-bound state. Mismatch binding by ADP-bound MutS triggers recruitment of MutL
to the mismatch and Exo1 to the strand break (strand discrimination signal). The ternary
complex composed of MutS and MutL stimulates protein-protein interaction with Exo1,
which brings DNA bending or looping. It is very important that MutS should remain
bound at the mismatch to communicate with the nick. In terms of protein-protein interaction,
mismatch-bound MutS transmits a signal for MMR initiation and proceeds
Exo1-catalyzed excision from the nick. Once Exo1 reaches to the mismatch, ADP bound to
MutS is exchanged to ATP, leading to formation of sliding clamp. ATP-bound MutS
slides away from the mismatch and dissociate from the mismatch, which allows excision to
proceed for removal of the mismatch.
In summary, we demonstrated that ATP hydrolysis of MutS and its sliding to the
strand break are not necessary to communicate between the mismatch and the nick during
initiation step of MMR. However, MutS should remain bound at the mismatch to
communicate with the nick until Exo1 reaches to the mismatch from the mismatch.
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Although all the finding in this study did not direcrly address which model is correct, they
partially resolved puzzling question of how MutS transmits a signal from the mismatch
and to the distal nick to initiate MMR, providing significant support that is not reliable only
on “sliding” model.
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70

Figure 4.8 Models for signaling between the mismatch and the strand discrimination
signal of MMR event.
The “sliding” model (left) proposes that ADP-bound MutS searches for a mismatch and
mismatch binding induces exchange of ADP for ATP, resulting in formation of a sliding
calmp. ATP-bound MutS then slides away from the mismatch in an ATP-hydrolysis
independent manner. The “stationary” model (right) postulates that ATP-bound MutS
binds to the mismatch and remains bound to the mismatch, while interactions of MMR
proteins are attributed to DNA bending or looping that brings two physical distant sites in
proximity. In this model, ATP hydrolysis of MutS is required for proofreading mismatch
reconition and inducing MutS interactions with other MMR proteins that trigger
downstream signaling of MMR.
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Figure 4.9 Proposed model for initiation of MMR.
ADP-bound MutS recognizes a mismatch, and recruits MutL to the mismatch and Exo1
to the strand break. MutS-MutL-DNA mismatch complex interacts with Exo1 at the 5'
nick by DNA bending or looping. MutS remains bound at the mismatch, thereby
transmitting the signal for downstream MMR events. DNA excision requires
mismatch-bound MutS ExoI and a distal nick. As Exo1 reaches the mismatch, MutS
slides away from the mismatch, removing steric hindrance, which would otherwise result in
termination of DNA excision.
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APPENDIX
LIST OF ABBREVIATIONS

A: Adenine
AML: Acute Myeloid Leukemia
ATP: Adenosine triphosphate
Beta Mercaptoethanol
bp: Base pair (s)
BSA: Bovine Serum Albumin
C: Cytosine
C strand: Complementary Strand
cDNA: complementary DNA
CV: Column Volume
ddH2O: double distilled water
DNA: Deoxyribonucleic acid
dNTPs: deoxy Nucleotide Triphosphate
DSB: Double-strand Break
dsDNA: double strand DNA
DTT: Dithiothreitol
EDTA: ethylediamine tetracetic acid
EGFR: Epidermal Growth Factor Receptor
EMSA: Electrophoretic Mobility Shift Assay
EtBr: Ethidium Bromide
EtOH: Ethanol
EXOI: Exonuclease I
EXOV: Exonulcease V
FBS: Fetal Bovine Serum
G: Guanine
GST: Gluthathione-S-transferase
HNPCC: Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome)
ID: Insertion/Deletion
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IPTG: Isopropyl-1-thio-β-D-galactopyranoside
Lac I: Lac Repressor
LS: Lynch Syndrome
MMR: Mismatch Repair
MSI: Microsatellite Instability
MutLα: Complex of MLH1 and PMS2
MutLβ: Complex of MLH1 and PMS1
MutLγ: Complex of MLH1 and MLH3
MutSα: Complex of MSH2 and MSH6
MutSβ: Complex of MSH2 and MSH3
nm: nano meter
nt: nucleotide
NaOAc: Sodium Acetate
NFDM: Non-Fat Dry Milk
OD: Optical Density
O/N: Overnight
PAGE: Polyacrylamide Gel Electrophoresis
PCNA: Proliferating Cell Nuclear Antigen
PCR: Polymerase Chain Reaction
PBS: Phosphate-buffered saline
PMSF: Phenylmethylsulfonylfluoride
PK: Protein Kinase
RFC: Replication Factor C
RPA: Replication Protein A
RT: Room Temperature
RPM: Revolutions per Minute
SNP: Single Nucleotide Polymorphism
SSB: single-stranded binding
SSCP: Single-strand Conformation Polymorphism
ssDNA: Single-stranded DNA
SDS: Sodium Dodecyl Sulfate
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T: Thymine
TBE : Tris/Borate/EDTA
TBS : Tris-buffered saline
TE : Tris-EDTA
TES : Tris-EDTA saline
UV: Ultraviolet
V Strand: Viral Strand
WB: Western Blot
X-gal: 5-bromo-4-chloro-3-indolyl-βD-galactosidase
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